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Abstract
Background: People with type 2 diabetes (T2D) may go undiagnosed and subsequently be
hospitalized with T2D.
Objective: Determine the percentage of Canadians, with unreported T2D, who experience a
T2D hospitalization
Methods: Using linked dataset, respondents who reported no diabetes in the Canadian
Community Health Survey, were followed in the Discharge Abstract Database for T2D
hospitalization event.
Results: 0.56% of men and 0.44% of women, who reported no diabetes, were hospitalized
with T2D. Older Age, higher BMI and worse self-reported health increased T2D
hospitalization in both men and women. In women, drinking alcohol, smoking tobacco and
lower physical activity were associated with an increase in T2D hospitalization.
Conclusion: Significant proportion of Canadians experience a T2D hospitalization when selfreporting undiagnosed diabetes. Potential risk factors were identified; however, further
research needs to focus on understanding these relationships.

Keywords
Undiagnosed diabetes, type 2 diabetes, preventable hospitalizations, diabetes in Canada,
linked dataset, Canadian Community Health Survey
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Summary for Lay Audience
Type 2 diabetes (T2D) is a growing public health concern and early detection and
management is key to controlling the pandemic. Since T2D can be present for a long time
before patients start experiencing symptoms, some Canadians may be unaware of having the
condition. These individuals may eventually present to the hospital with related
complications.
The objective of this thesis was to determine what percentage of Canadians who reported not
having T2D, might actually have the disease and end up in the hospital with related
condition. This thesis assessed whether the percentage of Canadians who reported no
diabetes but were hospitalized with T2D related condition changed over time. Lastly, this
thesis looked at potential factors that might increase or decrease T2D hospitalization risk
among this group.
This thesis utilized a national self-reported survey (Canadian Community Health Survey
[CCHS]) and national hospitalization records (Discharge Abstract Database [DAD]).
Canadians who responded to the CCHS and reported no previous T2D diagnosis were
followed in the DAD to see if they experienced a related hospitalization.
This thesis found that 0.56% of men and 0.44% of women were hospitalized with T2D even
though they reported no diabetes. This percentage increased with each year for men between
2000 to 2009 from 0.41% to 0.71%. With increasing age, higher BMI and self-reported poor
health, Canadians were more likely to be hospitalized with T2D. In Canadian women,
alcohol drinking prevented T2D hospitalization, while smoking tobacco, and lower physical
activity were associated with increase in T2D hospitalization.
Identifying T2D early could be an effective strategy to minimize the long‐term impacts of the
disease. Future research should focus on linking other administrative datasets, such as
physician billing or laboratory results to get a full picture of this problem.
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Chapter 1

1

Diabetes in Canada

This chapter will provide background information to contextualize the study rationale by
introducing diabetes, discussing the health and economic consequences of diabetes and
defining undiagnosed diabetes and its health consequences. Lastly, this chapter will
identify the study objectives.

1.1 Types of diabetes
Diabetes is a chronic disease that occurs either when the pancreas does not produce
enough insulin or when the body does not respond appropriately to insulin (a hormone
that is released by the pancreas to regulate blood sugar).[1] Although many types of
diabetes have been described, there are three main types: type 1, type 2 and gestational
diabetes.[2] Type 1 diabetes, an autoimmune disease, is characterized by decreased
insulin production. It requires daily administration of insulin for management.[2] Type 2
diabetes (T2D), results from the ineffective use or production of insulin.[2] Gestational
diabetes is characterized by hyperglycemia during pregnancy and typically disappears
following childbirth.[2] Other types of diabetes are uncommon and include those
associated with genetic defects, surgeries, and specific medications that affect the body’s
ability to produce or respond to insulin.[2]

1.2 Diabetes prevalence and incidence
The prevalence of diabetes is growing in Canada and in other parts of the world,
especially T2D. In 2014, there were 422 million adults worldwide living with diagnosed
diabetes, compared to 108 million in 1980 (rising from 4.7% to 8.5%).[3] In Canada,
8.1% of the population was living with diagnosed diabetes between 2013 and 2014; an
increase of 37% from 2003 to 2004.[4] By 2025, the prevalence of diagnosed diabetes is
estimated to reach 12.1% (5 million people).[5] More than 90% of people with diagnosed
diabetes have T2D,[4] which is the focus of this thesis.
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Although a consistent rise in prevalence of T2D has been observed, the incidence of T2D
increased until 2006–2007, from 6.7 to 7.6 per 1,000 population, but then decreased to
6.3 per 1,000 population by 2013–2014.[4] This may be because Canadians with T2D
now live longer due to advancements in treatment of patients diagnosed with T2D.[6]
The number of Canadians living with T2D is also expected to increase in the coming
years due to the aging population.[4]

1.3 Health consequences of type 2 diabetes
With long-term T2D, there are risks of complications, typically categorized as
macrovascular (due to damage to larger blood vessels) and microvascular complications
(due to damage to small blood vessels).[7] Macrovascular complications include
cardiovascular diseases (CVD) such as heart attacks, strokes and insufficiency in blood
flow to legs.[7] Microvascular complications include retinopathy, nephropathy and
neuropathy.[7]
Cardiovascular disease is an umbrella term for all types of diseases that affect the heart or
blood vessels.[7] This includes coronary heart disease, which can cause heart attacks,
stroke, and peripheral artery disease.[7] People with T2D are two to four times more
likely to have CVD compared to people without T2D; CVD accounts for a large
proportion of the excess mortality related to T2D.[8–10] T2D has been associated with
earlier development of CVD; men and women with T2D tend to be about 15 years
younger than those without T2D in the same CVD risk category.[10]
Diabetic retinopathy, typically occurs in individuals who have had T2D for several
years.[7] It is caused by small blood vessel damage to the back layer of the eye.[7]
Diabetic retinopathy is a leading cause of blindness and visual disability.[7] Up to 21% of
patients with T2D have retinopathy at the time of diagnosis, and most develop some
degree of retinopathy over time.[11] The prevalence of diabetic retinopathy has been
shown to vary from 28.8% in persons who had T2D for less than five years to 77.8% in
persons who had T2D for 15 or more years.[12]
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Nephropathy is also caused by damage to small blood vessels in the kidneys.[7] This can
cause kidney failure, and lead to death.[7] In developed countries, diabetic nephropathy is
a leading cause of dialysis and kidney transplant.[7] Approximately, 30 to 50% of
individuals with T2D have nephropathy; the prevalence of nephropathy ranges between
25% in younger T2D patients (<65 years old) to nearly 50% in older T2D patients (65
years old).[13]
Lastly, neuropathy, the most common complication of T2D, is nerve damage caused by
hyperglycemia and decreased blood flow to small blood vessels.[7] This nerve damage
can lead to sensory loss, gastrointestinal side effects, impotence in diabetic men.[7]
Overall, two thirds of T2D patients have objective evidence for some variety of
neuropathy, but only about 20% have symptoms.[14] The prevalence of neuropathy has
been shown to be 22% in youth with T2D.[15]

1.4 Economic consequences of type 2 diabetes
T2D has a number of economic consequences including medical costs, lost productivity,
premature mortality, and intangible costs in the form of reduced quality of life.[16] The
global economic burden of T2D was estimated to be $1.3 trillion USD in 2015 which
accounts for 1.8% of the world’s GDP.[16] Indirect costs, such as reduced productivity,
work absences and inability to work due to T2D related disability, accounted for 35% of
the total burden. Relative to GDP, T2D has a significant impact on North America as
well as in middle-income countries.[16] The absolute costs are expected to increase to
$2.1 trillion USD by 2030. This translates to an increase in costs as a share of global
GDP from 1.8% in 2015 to a 2.2% in 2030.[17]
The economic burden of T2D in Canada is estimated to increase from $6.3 billion
annually in 2000 to $16.9 billion by 2020.[18] T2D associated costs accounted for $3.5%
of public health care spending in Canada with direct costs representing about 17% of the
total cost.[18] Diabetes Canada has projected the overall direct cost of T2D to be $3.1
billion in 2020.[18]
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These health care costs of T2D arise due to the need for acute inpatient hospitalizations,
physician visits, prescription medications and assistive devices.[19] Inpatient
hospitalization accounted for nearly 50% of attributable costs in incident T2D cases.[19]
Between 2011/2012 and 2021/2022, 2.16 million new cases of T2D are estimated to
result in $15.36 billion in Canadian health care costs, almost two-thirds of which will be
spent on acute hospitalizations and physician services.[20]

1.5 Undiagnosed type 2 diabetes
The onset of T2D is characterized by a gradual increase in fasting and post-prandial (i.e.
after meals) blood sugar. It can take 9-12 years before glycemic levels are sufficiently
high to lead to symptoms and a diagnosis of T2D.[21] Consequently, individuals who
have T2D can spend a significant period of time unaware that they have the disease.[2]
This is referred to as undiagnosed T2D; and is typically defined as those whose T2D has
not been diagnosed by a physician but whose plasma glucose levels satisfy established
criteria for T2D.[22] During this period, patients may not receive the treatment that they
need for diabetes, which may result in development of complications before diabetes
diagnosis.[2] These complications can include heart disease, stroke, kidney failure, nerve
damage, blindness, erectile dysfunction and amputation; complications which can
impose enormous strains on the health care system.[23]
As such, the Diabetes Canada 2018 clinical practice guidelines recommend that all
individuals be evaluated annually for T2D risk based on their demographic and clinical
profile. The guidelines recommend that people aged 40 years and over be screened every
three years for T2D or more frequently (every 6 to 12 months) for those at very high
risk.[24] The hope is to capture T2D early in its progression and prevent the development
of T2D related complications. Despite these practice guidelines, the Public Health
Agency of Canada reported that the prevalence of total T2D may be underestimated by
30% as a result of undiagnosed T2D.[25]

1.5.1

Health consequences of undiagnosed type 2 diabetes

The health outcomes are worse for individuals living with undiagnosed T2D compared
with individuals who have been previously diagnosed.[26–28] In hospitalized patients,
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undiagnosed T2D patients, compared to known T2D patients, had an increased risk of
morbidity, mortality, extended hospital length of stay and more adverse outcomes
following discharge.[26] Patients with previously undiagnosed T2D were 28% more
likely to experience death within 30 days from myocardial infarction compared to
patients without T2D.[27] Among those who have undergone coronary bypass
operations, 5.2% had undiagnosed T2D and faced a higher mortality rate than those with
diagnosed T2D.[28]
Similar data exist in Canada, where those with T2D diagnosed at a later stage were more
likely to be hospitalized and had a longer length of hospital stay compared with those
with an early diagnoses.[29] Cardiovascular disease had a greater impact on females with
T2D than males, especially when diagnosed at a later stage.[29] Females who were
diagnosed with T2D late had three to four times increased risk of CVD mortality and
CVD hospitalizations compared with their male counterparts who were diagnosed
late.[29]
All-cause mortality risk has shown to be similar in subjects with diagnosed and
undiagnosed T2D, despite undiagnosed T2D patients having a lower cardiovascular risk
profile than those with diagnosed T2D.[30] A Canadian study reported that despite the
patient charts indicating dysglycemia among patients admitted to the hospital for
coronary heart disease, glucose monitoring occurred less than 30% of the time.[31]

1.6 Preventable hospitalizations and type 2 diabetes
T2D is a chronic condition that can be managed in a primary care setting. As such it is
considered to be an ambulatory care-sensitive condition (ACSC) as hospitalization for
this condition might be preventable.[32–34] There is evidence to suggest that a regular
source of primary care and maintaining glucose levels can result in fewer T2D
hospitalizations.[35,36] When individuals have access to primary care, are cared for
effectively, have screening in a timely manner and are supported in managing a chronic
condition like T2D, patients face a lower risk of acute complications and
hospitalizations[36,37]. Those with undiagnosed diabetes might face more complications
requiring presentation to hospital.[37]
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Between 2001 to 2005, an estimated 4.2 million Canadians aged 12 to 74 experienced at
least one preventable hospitalization; T2D related hospitalizations represented 30% of
these hospitalizations.[38] Studies conducted in single emergency departments in the
United States estimated that approximately 9% of patients who presented to the
emergency department for acute illness had previously undiagnosed T2D.[39–41] In
Europe, 9.5% of those presenting to hospital had previously undiagnosed T2D.[42] Those
with undiagnosed T2D were admitted to hospital predominantly for cardiac disorders,
nervous system disorders such as cerebral infarction, and infections/infestations.[42] In
Canada, there is little understanding of the proportion of patients with undiagnosed T2D
who present to hospital, along with a lack of data on trends in T2D related preventable
hospitalizations among undiagnosed T2D patients.
Overall, a decrease in T2D related preventable hospitalizations has been documented in
Canadian studies, which may suggest a sustained improvement in T2D care, despite the
increase in the T2D prevalence.[43,44] In Alberta and British Columbia, declining T2D
related preventable hospitalization was observed between 1998 and 2009.[43] Whereas in
Ontario, between 1994 and 1999, hospital admissions for hyperglycemic emergencies
decreased by 33%.[44] However, these studies investigated the temporal trends among
individuals with previously diagnosed diabetes.

1.7 Rationale and objectives
Diagnosing T2D at an early stage is key to preventing complications, avoiding
hospitalizations, and reducing health care costs.[45] It has been shown that the intensity
of glucose, blood pressure and cholesterol treatment after diagnosis is less important than
the time of treatment initiation.[45] Therefore, early detection of T2D is of utmost
importance as screening strategies can decrease the incidence of myocardial infarction,
decrease T2D related microvascular complications, and increase the number of Quality
Adjusted Life Years (QALY).[46]
Currently, no Canadian literature exists on the proportion of individuals with
undiagnosed diabetes who present to the hospital with T2D. Furthermore, no Canadian
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literature has examined national trends in T2D related hospitalizations among patients
with undiagnosed T2D.
Lastly, it is important to study the factors associated with undiagnosed T2D requiring
hospitalization and whether these determinants differ for males and females. There is
literature that explores sociodemographic, health-related and behavioural factors
associated with T2D hospitalization. However, these studies have not examined these
factors in the context of undiagnosed T2D patients. Therefore, the objectives of this
thesis are as follows:
Objective 1: Identify the percentage of men and women in Canada with undiagnosed
T2D who experience T2D related hospitalizations.
Objective 2: Explore temporal trends of T2D related hospitalizations among Canadian
men and women with undiagnosed T2D.
Objective 3: Explore the role of sociodemographic, health-related, and behavioural
factors associated with T2D related hospitalizations among Canadian men and women
with undiagnosed T2D.
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Chapter 2

2

Literature Review

This chapter will lay out the etiology of T2D and its potential risk factors. This chapter
will explain how T2D is diagnosed, which will lay a foundation to further discuss the
prevalence, temporal trends and risk factors for undiagnosed T2D. Furthermore, this
chapter will review the prevalence of T2D hospitalizations as well temporal trends and
risk factors of T2D hospitalization. Literature looking at undiagnosed diabetes in hospital
setting will be summarized. Lastly, this chapter will summarize the in-depth literature
review, restate the objectives of this study and present hypotheses.

2.1 Glucose regulation in type 2 diabetes
In order to ensure normal body function, the human body maintains a tight control of its
blood glucose levels.[47] This is accomplished by a highly complex network of various
hormones and neuropeptides released mainly from the brain, pancreas, liver, intestine as
well as adipose and muscle tissue.[47] The pancreas plays a key role by secreting the
blood sugar-lowering hormone insulin and glucagon.[47] When blood glucose levels are
low, the pancreas secretes glucagon, which increases blood glucose levels through
glycogenolysis (conversion of glycogen into glucose).[47] When blood glucose levels are
high, insulin is released to trigger glucose uptake into insulin-dependent muscle and
adipose tissues as well as to promote glycogenesis (conversion of glucose into
glycogen).[47]
Disturbances in the interplay of the hormones and peptides involved may lead to
metabolic disorders such as T2D.[48] T2D usually begins with insulin resistance, a
condition in which muscle, liver, and fat cells do not use insulin well.[48] As a result, the
body needs more insulin to help glucose enter cells. At first, the pancreas produces more
insulin to keep up with the added demand.[48] This is referred to as the prediabetes stage.
In the prediabetes stage the blood sugar levels might not be high enough to be considered
T2D, however, long-term complications such as microvascular and macrovascular
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disorders may manifest in some people.[49] Over time, the pancreas cannot produce
enough insulin and blood glucose continue to rise[48]
Although T2D may remain asymptomatic for many years, some of the symptoms as a
result of hyperglycemia include increased thirst, increased hunger, dry mouth, frequent
urination, unexplained weight loss, fatigue, blurred vision, headaches and rarely loss of
consciousness.[3]

2.2 Type 2 diabetes risk factors
Numerous risk factors have been investigated and linked to T2D. Overweight and obesity
are the most significant risk factors. Adults with a body mass index (BMI) of 40 or higher
are 7.37 times more likely to be diagnosed with T2D.[50] For people with obesity, T2D is
associated with poor control of blood sugar, blood pressure and cholesterol levels and
many of the health complications of T2D become more severe when they are
compounded by overweight or obesity.[50–52]
Other factors such as age, sex, marital status, education, socioeconomic status (SES) and
ethnicity have also been linked to T2D. For instance, the prevalence and incidence of
diagnosed T2D has been shown to increase with age and is higher among males (8.7%
and 6.5 per 1,000 population) than among females (7.6% and 5.3 per 1,000
population).[4] A systematic review and meta-analysis of six observational studies
conducted in different parts of the world found that marital status also increased the risk
of T2D by 26% when there was a spousal history of T2D.[53] Furthermore, a recent
systematic review and meta-analysis of 23 observational studies from different parts of
the world concluded that compared with a higher educational level and income, lower
educational levels and income were associated with an increased risk of T2D.[54] Social
determinants of health not only increase the risk of developing T2D but can also have an
impact on health outcomes, such as glycemic control, low density lipoproteins and blood
pressure for a person with T2D.[55,56] Additionally, ethnicity has been linked with T2D.
For example, a study in the United States found that compared with white participants,
Black and Asian participants were twice as likely to have T2D.[57] The incidence of T2D
has been shown to be highest among South Asians, particularly 20 to 29-year-olds, with
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rates 2.2 times that of white individuals and 3.1 times that of Chinese individuals.[58]
Lastly, multiple studies have shown higher rates of T2D among Indigenous people in
Canada compared to non-Indigenous Canadians while controlling for other
sociodemographic characteristics.[2,59,60]
Although it does not have a clear pattern of inheritance[61] at least 38 T2D associated
genes have been identified, however, only about 10% of the heritability of T2D can be
explained by these genes.[61–63] Many affected individuals have at least one close
family member, such as a parent or sibling, with the disease.[64] The increased risk is
likely due to shared genetic factors and lifestyle influences that are shared by members of
a family.[63]
Modifiable health behaviours such as unhealthy diet, smoking tobacco, alcohol drinking
and physical inactivity have also been associated with T2D. A systematic review and
meta-analysis of 25 cohort studies found that active smoking is positively associated with
an increased risk of T2D.[65] The association between the number of cigarettes smoked
and T2D risk was consistent with a dose-response phenomenon.[65] Moderate alcohol
drinking, relative to abstainers (current non-drinkers and never drinkers), played a
protective role against T2D according to a systematic review of 38 observational
studies.[66] However, reductions in risk appeared to be specific to women, who exhibit a
decreased risk of T2D with moderate alcohol consumption.[66] Other health behaviours
such as increasing the amount of green leafy vegetables in an individual’s diet has been
shown to help reduce the risk of T2D.[67,68] Habitual consumption of sugar sweetened
beverages has been shown to be associated with a greater incidence of T2D,
independently of adiposity.[69] Furthermore, meat consumption has shown to increase
risk of T2D.[70] Lastly, there is strong evidence for an inverse association between
physical activity and risk of T2D, which may partly be mediated by reduced
adiposity.[71]

2.3 Onset of type 2 diabetes
A highly cited study by Harris et al. estimated the onset of T2D to be 9 to 12 years before
its clinical diagnosis.[21] This was based upon the prevalence of retinopathy at time of
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diagnosis of T2D. The authors estimated that 20.8% of patients with diagnosed T2D in
United States and 9.9% of patients in Australia had retinopathy at time of T2D
diagnosis.[21] Under the assumption that retinopathy increased linearly with longer
duration of T2D, they extrapolated that the onset of detectable retinopathy occurred 4 to 7
years before diabetes diagnosis.[21] Because research has indicated that T2D may be
present for 5 years before retinopathy becomes evident, authors concluded that in some
cases, the onset of T2D may occur 9 to 12 years before its clinical diagnosis.[21]
A more recent study aimed to extrapolate the mean duration of undiagnosed T2D from
the proportion of subjects with observable retinopathy at diagnosis of T2D.[72] They
performed eyes examination and ascertained date of first diagnosis of T2D.[72] Of the
295 patients examined, 14.68% had some form of retinopathy at time of diagnosis. The
findings suggested that detectable retinopathy occurred 5.8 years before actual
diagnosis.[72] The fact that a period of dysglycaemia is likely to predate development of
retinal changes, this study implied that the duration of undiagnosed T2D is longer, about
10 years.[72]
Even still, there was debate as to whether the relation between retinopathy and duration
of T2D is a linear one.[73] Porta et al. further argued the plausibility of such a long
duration of undiagnosed T2D in countries with regulated health care systems in which
blood glucose concentrations are ideally measured more often than every 10 years due to
T2D guidelines.[73] Using Akaike Information Criterion and coefficient of determination
to choose the best-fitting model, the authors concluded that T2D may be present 4 to 6
years before clinical diagnosis.[73]

2.4 Diagnosis of type 2 diabetes
The following tests can be used in clinical setting to diagnose T2D: fasting blood glucose
(FPG) test, glycated hemoglobin (A1C) test, oral glucose tolerance (OGT) test and
random glucose test (RGT).[74] An FPG test is typically taken after an overnight fast and
[74] T2D is diagnosed with a FPG level of 126 mg/dL (7 mmol/L) or higher on two
separate tests.[74] A1C is a blood test which measures blood sugar attached to
hemoglobin, and represents blood sugars over 2-3 months.[74] The higher the blood
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sugar levels, the more hemoglobin have sugar attached.[74] An A1C level of 6.5 percent
or higher on two separate tests indicates a T2D diagnosis.[74] An OGT test requires
individuals to fast overnight.[74] A sugary liquid is consumed the day of the test and
blood sugar levels are tested periodically for the next two hours.[74] A reading of more
than 200 mg/dL (11.1 mmol/L) after two hours indicates T2D.[74] Lastly, a RGT can be
administered anytime to measure blood glucose levels and a reading of more than 200
mg/dL (11.1 mmol/L) may suggest diabetes.[74]
The diagnostic criteria for T2D are based on thresholds of glycemia that are associated
with microvascular disease, especially retinopathy.[74] To confirm T2D cases, a plasma
glucose in the T2D range should be confirmed with a secondary test in asymptomatic
individuals.[74] This is because hyperglycemia detected under acute event or other stress
may be transitory.[75] This does not in itself confirm a diagnosis of T2D.[75] If two tests
are above the T2D threshold, then a diagnosis of T2D is confirmed.[74,75] Table 2.1
from Diabetes Canada guidelines summarizes T2D diagnostic tests criteria.[74]
Table 2.1: Type 2 diabetes diagnosis criteria
Test
FPG
A1C
OGT
RGT

Normal Range
 7.0 mmol/L
 6.5%
 11.1 mmol/L
 11.1 mmol/L

2.5 Undiagnosed type 2 diabetes
Globally, nearly half of all T2D cases are considered undiagnosed.[76] However, the
prevalence of undiagnosed T2D shows geographic variation. Undiagnosed T2D has been
reported to be as low as 10% of total T2D (0.9% of population) in higher income
countries such as Ireland,[77] and as high as 55% of total T2D (3.96% of population) in
low income countries such as rural Bangladesh.[78]
A Canadian study assessed the prevalence of undiagnosed T2D in patients over the age of
40 who visited their family physicians for routine care.[79] Patients were asked to fill out
a questionnaire indicating whether they had been previously diagnosed with T2D. Those
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who indicated no previous diagnosis were tested for T2D.[79] They found previously
undiagnosed T2D in 2.2% of patients after screening in the primary care setting.[79] A
higher percentage of men (2.4%) than women (2.0%) had previously undiagnosed
T2D.[79] However, the authors noted that these prevalence estimates maybe biased since
the study population may not have been entirely representative of the Canadian
population over 40 years of age.[79] For instance, the study sample had a T2D prevalence
of 16.4%, which is much higher than the rate of T2D in the general Canadian
population.[79]
A more recent Canadian study conducted in 2005 using Canadian Health Measure Survey
(CHMS) data aimed to estimate the prevalence of undiagnosed T2D in Canada.[80]
CHMS collected self-reported health data through household interviews.[80]
Additionally, the CHMS collected direct physical measures such as biospecimens using
mobile examination centers.[80] This study found that 1.13% (~20% of total T2D) of the
Canadian adult population had undiagnosed T2D based on FPG levels; whereas 3.09%
(~40% of total T2D) of the Canadian adult population was classified as undiagnosed T2D
using A1C level as a criterion.[80] Undiagnosed T2D was defined as not self-reporting
T2D and having a blood glucose level that met the diagnostic criteria.[80] The proportion
of undiagnosed T2D prevalence was higher for males compared with females (22% vs.
18% of total T2D, respectively) under the FPG criterion, whereas under the A1C
criterion, the proportion of undiagnosed T2D prevalence was lower for males compared
with females (37% vs. 46% of total T2D, respectively).[80] Studies have shown that the
A1C test has a low sensitivity and high specificity for identifying T2D, which varied as a
function of age and race.[81,82] This is to say that while the A1C test at the 6.5%
diagnostic threshold may be good at ruling out T2D, it may wrongly classify non-diabetic
individuals as having T2D. Furthermore, the study used data which excluded Canadians
living on reserves or on Crown lands, people residing within institutions, those from
certain remote geographical regions, and full-time members of the Canadian Forces.[80]
Therefore, these estimates might also be biased in estimating the true prevalence of
undiagnosed T2D.[80]
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2.5.1

Temporal trends in undiagnosed type 2 diabetes

There is evidence to suggest that undiagnosed T2D as a proportion of total T2D has
significantly declined since the 1970s to early 2000s due to rigorous screening for those
at higher risk.[83] Undiagnosed T2D as proportion of total T2D declined from 40% in
1988 to 31% in 2012 in the United States (US) according to one study.[57] This was true
across age, sex, race, educational level and income groups except for younger
participants (age 20-44, 40.4% in 1988 to 40.4% in 2012).[57] Similarly, in the US, the
incidence of T2D increased sharply during 1990 and 2008, before leveling off with no
significant change during 2008 and 2012.[84] The incidence per 1,000 persons was 3.2 in
1990, 8.8 in 2008, and 7.1 in 2012.[84]
Certainly there has been a sharp decline in undiagnosed T2D as a proportion of total
T2D; however, in the US, temporal trends in the crude prevalence of undiagnosed T2D
remained stable over time.[85–87] Rates of undiagnosed T2D fluctuated between 3.1% to
3.9% of total population during the period of 1988 and 2012. Even though more T2D
cases were detected, the crude prevalence of undiagnosed T2D did not change. This may
be due to an increase in new cases of T2D. Obesity is on the rise, putting people at higher
risk for developing T2D, especially in young adults.[88,89] The leveling off of T2D
incidence rates in 2012 might not necessarily suggest a decrease in T2D cases. Younger
adults who may have T2D might go unnoticed and hence would explain the unchanged
crude prevalence of undiagnosed T2D despite higher detection rates.
The temporal trends studies mentioned above used survey data that used single FPG,
OGT or AlC tests measurements to determine undiagnosed T2D in the US. Such single
measurements may not provide a confirmatory T2D diagnosis. A more recent study in the
US re-examined the crude prevalence of confirmed undiagnosed T2D. Confirmed
undiagnosed T2D was defined as both elevated levels of fasting glucose and A1C (fasting
glucose ≥7.0 mmol/L and A1C ≥6.5%) in persons without diagnosed T2D.[90] They
estimated undiagnosed T2D crude prevalence increased during the past two decades
(from 0.89% in 1988 to 1994 to 1.2% in 2011 to 2014) but has decreased over time as a
proportion of total T2D cases.[90] This is much lower than the prevalence provided in the
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studies above. Additionally, this study also suggested an increase in crude prevalence of
undiagnosed T2D whereas the previous studies noted a stabilization of undiagnosed T2D.
Other high-income countries with similar health care systems, such as Germany, have
also seen a decline in the prevalence of undiagnosed T2D as proportion of total T2D
(3.8% to 2.0% between 1997-2011).[91] However, the crude undiagnosed T2D
prevalence has remained stable.[91] Although there is literature on the estimated
prevalence of undiagnosed T2D in Canada,[80] thus far, no literature exists on trends
over time in the prevalence of undiagnosed T2D. With increasing rates of obesity
observed in Canada,[92,93] incidence of new T2D might also increase leading to no
change observed in the crude prevalence of T2D despite the increase in detection rate.

2.5.2

Undiagnosed type 2 diabetes risk factors

Both ethnicity and obesity have been linked not only with diagnosed T2D, but also with
undiagnosed T2D. Members of some minority groups not only have elevated risk of
developing T2D but are also more likely to go undiagnosed; especially in Asian,
Hispanics and black participants in some studies.[94–97] For example, undiagnosed T2D
crude prevalence was two times higher in non-Hispanic blacks and Mexican Americans
than in non-Hispanic whites.[86] Obesity, a risk factor for undiagnosed T2D, is also
higher among racial minority groups.[98,99] Another study results found undiagnosed
T2D was more common in overweight or obese adults, older adults and racial/ethnic
minorities (including Asian Americans).[90]
Some sociodemographic characteristics such as income, education, sex and rurality are
also risk factors for undiagnosed T2D. Individuals with less than a high school education
were twice as likely to have undiagnosed T2D compared to individuals with higher
education level.[100] Individuals in lower income quintiles were also twice as likely to
have undiagnosed T2D compared to individuals in middle income groups.[100] At the
national level, undiagnosed T2D prevalence was higher among men (5.0%) than among
women (3.2%).[101] Furthermore, a Canadian study found higher rates of undiagnosed
T2D in rural patients compared to urban patients (2.0% vs 2.9%, respectively).[79]
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There is also evidence to suggest that receiving health care in the past year and routine
patterns of primary health care utilization were associated with undiagnosed
T2D.[102,103] People with undiagnosed T2D were more likely than those with
diagnosed T2D to report not having made any health care visits in the past year (39.2%
versus 13.4%, respectively) and not having a place to go for primary health care (16.6%
versus 3.7%, respectively).[102] A Canadian study examined risk factors for undiagnosed
T2D and classified patients diagnosed with T2D as ‘early’ or ‘late’ depending on when
T2D related comorbidities or complications had developed at the time of
diagnosis.[104] This study found that patients with a late T2D diagnosis were less likely
to report having a regular medical doctor.
Factors such as smoking tobacco, alcohol drinking, physical activity and fruit and
vegetable consumption have been studied and associated with undiagnosed T2D. Both
smoking and drinking were shown to be risk factors for undiagnosed diabetes.[105]
Current smokers compared to those who have never smoked had 1.47 higher odds of
undiagnosed diabetes.[105] Daily drinking also put individuals at 1.64 higher odds of
having undiagnosed diabetes.[105] In contrast, a Chinese study found current smoking to
be a protective factor against undiagnosed diabetes.[106] Another study conducted in
United Kingdom investigated the association between fruits and vegetable consumption
in subjects aged 40 to 64 years.[107] Participants underwent an OGT test, and their fruit
and vegetable consumption was assessed.[107] Frequency of average yearly vegetable
consumption was inversely associated with the risk of having undiagnosed T2D (Odds
Ratio [OR]= 0.18) and the effect remained significant after adjusting for age, sex and
family history; however the effect diminished after adjusting for BMI.[107] Individuals
who reported frequent average yearly fruit consumption were less likely to have
undiagnosed T2D than were those who reported infrequent consumption, but this
relationship was not significant (OR = 0.52). [107] In contrast, another study found that
increase in vegetable consumption was a protective factors against undiagnosed diabetes
but only in women (OR = 0.56).[108] Additionally, 70% of undiagnosed T2D individuals
reported physical inactivity, which was much higher than those with diagnosed T2D
(56%) and non-T2D individuals (50%).[109]
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2.6

Preventable hospitalizations

As defined by the Canadian Institute of Health Information (CIHI), ACSC includes
epilepsy, chronic obstructive pulmonary disease, asthma, heart failure and pulmonary
edema, hypertension, angina and diabetes.[110] Hospitalization due to those condition
are considered potentially preventable; rates of preventable hospitalization has been used
an indicator of the quality and performance of primary care system.[110] T2D related
hospitalization are considered potentially preventable, as uncontrolled T2D can result in
complications that can require extensive care, including hospitalization.[111,112].
In 2011, preventable hospitalizations comprised approximately 6% of all
hospitalizations.[38] Among those with a preventable hospitalization, 20% were
hospitalized for T2D.[38] In European countries with a similar health care system as
Canada, T2D hospitalization ranged from 4% to 14% of total preventable
hospitalizations.[113] In the Canadian context, a study from western provinces found that
the rate of yearly hospitalization among patients diagnosed with T2D was 1.1% in
Alberta and 0.8% in British Columbia.[43] In Ontario, 31.8% of T2D patients had at least
one emergency department visit and 13.7% had a hospitalization due to T2D related
hospitalization.[114]

2.6.1

Temporal trends in type 2 diabetes related hospitalizations

Overall, a decrease in T2D related hospitalizations has been documented in studies,
which may suggest a sustained improvement in T2D care, despite the increase in the T2D
prevalence.[33,43,115] Overall, preventable hospitalization rates in Canada have
decreased by 22% between 2001-2002 and 2006-2007, after population growth and aging
were taken into account.[33] This decline is greater than the 14% drop observed for all
medical hospitalizations over the same period.[33] In 1998, the adjusted preventable
hospitalization rate for T2D among diagnosed T2D patients was 2.9% in Alberta and
1.7% in British Columbia, compared to 1.1% and 0.8% in 2009, respectively.[43]
Overall, the number of people with T2D more than doubled in both provinces between
1998 and 2009.[43] The number of hospitalizations also increased but at a much slower
pace, translating into decreasing rates of hospitalization over the study period.[43]
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Between 1994 and 1999, hospital admissions for hyperglycemic emergencies in Ontario
decreased by 33%. There was also a marked decline in hospital admissions for
hypoglycemia and an associated decrease in emergency department visits for T2D.[44]
Studies examining trends of T2D related preventable hospitalization among patients
diagnosed diabetes have shown a declining trend in the US as well.[43,116,117] In the
US, T2D related preventable hospitalization (including uncontrolled T2D, short and long
term complications and lower extremity amputations) declined 27% from 1988 to
2008.[116] This was true for all ages except for those between 18 and 44 who showed no
significant change in the rates of T2D related hospitalization.[116] During the period of
2005 to 2014, the annual count of T2D hospitalizations increased from 500,444 to
577,040. However, no changes were observed in the rate of T2D related hospitalization
among individuals with T2D.[117] Subgroup analysis revealed a significant increase in
T2D related hospitalizations due to acute complications in the age-group 18–44
years.[117] The slight increase in hospitalization rates due to T2D short-term
complications balanced by a slight decrease in hospitalization rates due to uncontrolled
T2D led to no observable change in hospitalization rates during 2005 to 2015 in the
US.[117]

2.6.2

Preventable hospitalization and undiagnosed diabetes

Preventable hospitalization definitions pertains to hospitalizations experienced by
individuals diagnosed with ACSC. However, for the purpose of this thesis, the definition
was extended to include individuals who reported undiagnosed diabetes. If individuals
were diagnosed in a timely manner, they might have not developed conditions requiring
hospitalizations. Therefore, these hospitalization could have been prevented as well.

2.6.3

Risk factors of type 2 diabetes related hospitalization

Several sociodemographic risk factors such as sex, education, marital status and income
have been associated with increased rates of T2D related hospitalization. Hospitalized
individuals with T2D were shown to have lower educational status, lower household
income, and were unmarried compared with T2D patients in the never hospitalized
group.[118] For T2D, the hospitalization rate for men was about 16% higher than for
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women.[33] Socioeconomic effects of higher education, as well as individual income,
were important factors that affected disparities in T2D related hospitalization.[119] An
inverse gradient between income level and T2D related hospitalizations was observed.
Individuals with T2D in the lowest income quintile were 44% more likely to be
hospitalized compared to those in the highest quintile (16.4% versus 11.4%).[120] The
relationship between income and T2D related hospitalizations persisted after adjusting for
age, sex, comorbidity, frequency of physician visits, continuity of care, physician
specialty and geographic region.[120] Socioeconomic advantage increased the
hospitalization rate in both men and women alike.[121]
The proportion of patients hospitalized for T2D related complications increased with
age.[118] Furthermore, there is evidence to suggest the adjusted odds of hospitalization
for both males and females follows a parabolic path.[122] The relationship is such that,
among adults with T2D, the odds of hospitalization decreased with age until 60 years old
and then increased with advancing age.[122] Furthermore, a Canadian study examined
the hospitalization rate for individuals with T2D and found higher hospitalization rates
among those who were older; around 34% of participants with T2D were aged 65 or
older when hospitalized, compared with 12% of those aged 14 to 44.[123]
An individuals’ BMI can also influence T2D related hospitalization with studies
suggesting that both underweight and overweight, compared to normal weight, can
increase hospitalization risk. For example, more than half (52%) of the patients with T2D
related complications had a BMI lower than 24.[118] A Canadian study found that, men
(OR=1.24) and women (OR=1.25) who were overweight were at an increased risk for
general hospitalization compared to their counterparts with a normal weight.[124]
Participants with obesity had a higher risk of hospitalization: Hazard Ratio (HR)=1.82 for
those aged 25 to 44 years, HR=1.29 for those aged 45 to 64 years, and HR=1.46 for those
65 years and older.[125]
A study from Alberta, Canada found First Nations adults had almost four times the odds
of having a potentially preventable hospitalization or emergency department visit for
T2D compared to non-First Nations adults.[122] The rate of preventable hospitalizations
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among urban Métis adults was found to be twice that of non-Indigenous adults.[126]
Even when demographic, geographic and socioeconomic characteristics were taken into
account, Métis had 1.5 higher odds of preventable hospitalization, overall.[126] Most
commonly, these hospitalizations were for T2D or chronic obstructive pulmonary
disease.[126] Among persons aged 35 years or older, Indigenous men were twice as
likely to be hospitalized for T2D related illness compared to their non-Indigenous
counterparts.[127]
Another Canadian study found, after accounting for differences in service use, that
individuals living in rural areas of Ontario Canada were up to 1.8 times more likely to
visit an emergency department or be admitted to a hospital for management of T2D than
those living in urban communities.[44] Furthermore, those residing in remote areas of the
province were nearly three times as likely to suffer from preventable hospitalizations.[44]
More remote, northern areas had higher rates of admission for hypoglycemia and
emergency department visits for T2D throughout the period of study but experienced
comparable, or even greater declines in rates, as areas in southern Ontario.[44]
A study from the Canadian province of Alberta found that limited or increased use of
primary care among diabetic patients was associated with increased risk of a subsequent
hospitalization.[128] Compared to patients with 1 to 4 primary care visits, patients with
no visits to a primary care physician and those with 5 to 9 visits were 11% and 6% more
likely to experience a subsequent hospitalization, respectively.[128] This study concluded
that those who visited primary care too much or too little were more likely to have a
hospitalizations.[128] This may be because those with worse health use primary care
services more frequently. Additionally, not using primary care service can lead to
worsening of T2D related complications. In contrast, another Canadian study concluded
that primary care use may not be a significant predictor of subsequent hospitalization
among individuals with T2D; those who consulted with a family doctor in the past 12
months had equal hospitalization rates (24%) to those who did not consult a family doctor
in the past 12 months (24%).[123]
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Modifiable health behaviours such as smoking, drinking alcohol, physical activity and
diet have also been associated with T2D hospitalization events. An Australian study
found an increased risk of hospital admissions in smokers and physically inactive
patients.[129] Those who never smoked were less likely than former or current smokers
to be hospitalized (19%, 27% and 25%, respectively).[123] In contrast, regular alcohol
drinkers had lower hospitalization rates than those who drank occasionally or were nondrinkers.[123] Lastly, increased fruit and vegetable consumption has been associated with
a decrease in BMI and subsequent hospitalization.[130]

2.7 Undiagnosed type 2 diabetes detected in hospital
Several studies have been conducted to estimate the prevalence of T2D in a hospital
setting among previously undiagnosed T2D patients. In the US, a prospective cohort
study aimed to estimate the percentage of T2D cases in a hospital setting among
previously undiagnosed patients. Of the 508 patients admitted to the hospital emergency
department, 50 (9.8%) patients had an admission plasma glucose value in the T2D range.
The authors were able to conduct secondary confirmatory tests upon discharge in 70% of
the participants; 60% of these patients were diagnosed with T2D.[40] Another study, in
the US, used A1C test in emergency department to measure the rate of undiagnosed T2D
among patients with acute illness. They found previously undiagnosed T2D in 9% of
patients.[39] Of those aged 45 years and older, 70% had newly diagnosed dysglycemia,
while 55% of those aged 30 to 44 years were found to have newly diagnosed
dysglycemia. Of those aged 18 to 29 years, 33% were newly diagnosed with
dysglycemia. Furthermore, researchers in Germany estimated the prevalence of T2D in
patients (55 years of age and older) who were admitted to the hospital using A1C test. Of
the 5820 patients registered, 32.7% had a known history of T2D, whereas 9.5% had
previously undiagnosed T2D. Patients with previously undiagnosed T2D were admitted
to hospital predominantly for cardiac disorders (21.9%), nervous system disorders such
as cerebral infarction (15.0%), and infections/infestations (13.4%).[42]
Other studies have looked at the prevalence of undiagnosed T2D among patients
presenting to the hospital with chronic conditions such as heart disease, stroke and kidney
disease. Patients hospitalized with acute heart failure had a 27.9% prevalence of T2D,
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half of which were previously undiagnosed.[131] Another study found that the
prevalence of T2D was 62% in patients with heart issues, of which 40% had diagnosed
T2D and 22% had undiagnosed T2D.[132] In acute stroke patients, almost two-thirds
were classified as having T2D; 21% had diagnosed T2D, 15% had undiagnosed T2D, and
27% had pre-T2D at a 12 week follow-up.[133] In patients with acute coronary heart
disease, the prevalence of T2D was 48.4%, of which 31.8% had known history of T2D
and 16.6% had newly diagnosed T2D.[134] Lastly, amongst patients diagnosed with
chronic kidney disease – after adjusting for age, sex, and ethnicity – 32.9% had
diagnosed T2D, 24.2% undiagnosed T2D, and 17.1% had pre-T2D.[135] These studies
demonstrate that a significant portion of patients with chronic illness have undiagnosed
and therefore untreated T2D. This can be detrimental for the overall health and recovery
of the patients.

2.8 Summary
Diabetes can have profound impacts on patients as well as our healthcare system. Some
patients with T2D may go undiagnosed and untreated, which may lead to complications
including hospitalization. However, there remains limited research of Canadians with
undiagnosed T2D. While a decline in the percentage of T2D hospitalizations has been
observed until 2011 in Canada, no Canadian literature exists on how the percentage of
T2D hospitalizations among undiagnosed T2D patients has changed over time. It is also
important to study the factors associated with undiagnosed T2D requiring hospitalization
and whether these determinants differ for males and females.
The overall objective of this thesis is to investigate the percentage of Canadian men and
women who report no previous T2D diagnosis and whom experience a T2D related
hospitalization. Specifically, there are three objectives:
Objective 1: Identify the percentage of men and women in Canada who report no
previous T2D and experience a T2D related hospitalization.
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Hypothesis: The percentage of individuals with unreported T2D has been estimated to be
1.13%-3.09% of general population with men at higher risk.[80] It is hypothesized that
T2D hospitalizations will be higher among men compared to women.
Objective 2: Explore temporal trends of T2D related hospitalizations among Canadian
men and women with unreported T2D.
Hypothesis: With increasing rates of obesity observed in Canada,[92,93] incidence of
new T2D might also increase. Which can lead to no change observed in the crude
prevalence of T2D despite the increase in detection rate. It is hypothesized that that
percentage of T2D related hospitalizations among unreported T2D patients will remain
constant for both men and women.
Objective 3: Explore the role of sociodemographic, health-related and behavioural
predictors associated with T2D related hospitalization among Canadian men and women
with unreported T2D.
Hypothesis: The factors previously associated with T2D related hospitalization will be
associated with unreported T2D hospitalization. These factors include age, visible
minority, marital status, education, income, household size, rurality, BMI, self-reported
health, having a regular doctor, visiting doctor in past 12 months, alcohol drinking,
smoking tobacco, physical activity, and fruits and vegetable consumption. The risk
factors and the magnitude of the effect will differ for men and women.
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Chapter 3

3

Methods

This chapter will first describe in detail the datasets used for this project: Canadian
Community Health Survey and Discharge Abstract Database. The target population and
data collection methods will be summarized for each database. This linkage process will
also be explained. Additionally, this chapter will explain how the outcome variable and
the explanatory variables are constructed. Lastly, this chapter will lay out the analysis for
each objective of this thesis.

3.1 Linked datasets
In 2012, Statistics Canada approved the linkage of the Canadian Community Health
Survey (CCHS) 2000-2011 to the Discharge Abstract Database (DAD) 1999-2012.[136]
The purpose of this record linkage was to better understand and quantify the association
between behavioural, socio-economic, environmental risk factors, hospitalizations and
health outcomes at the individual and population level.[136] The DAD and the CCHS are
complementary sources of data. The DAD contains information on diagnosis and
intervention for each hospitalization event; however, the DAD does not contain
information on determinants of health, such as socioeconomic and lifestyle factors.[136]
Alternatively, the CCHS contains a rich source of information on health status and
determinants of health, but lacks the detail needed to study hospitalization events.[136]
Linking the DAD with the CCHS enables a more comprehensive understanding of what
brings Canadians in contact with acute care facilities.[136] Statistics Canada ensures
respondent privacy during linkage and subsequent analysis of linked files.[136] Only
employees directly involved in the linkage process can access the identifying
information.[136]

3.1.1

Canadian Community Health Survey

The CCHS is a cross-sectional survey that collects information related to health status,
health care utilization and health determinants for the Canadian population.[137] Data
collection for the survey began in 2000 and was repeated every two years.[137] Starting
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in 2007, data for the CCHS were collected annually instead of every two years.[137]
While a sample of approximately 130,000 respondents were interviewed during the
survey cycles 1.1, 2.1 and 3.1, the sample size was changed to approximately 65,000
respondents each year starting in 2007.[137]

3.1.1.1

Population

The CCHS covers the population 12 years of age and over living in the ten provinces and
the three territories.[137] Excluded from the survey's coverage are: persons living on
reserves and other Aboriginal settlements in the provinces, full-time members of the
Canadian Forces, the institutionalized population, children aged 12 to 17 living in foster
care, and persons living in the Quebec health regions of Région du Nunavik and Région
des Terres-Cries-de-la-Baie-James.[137] Altogether, these exclusions represented less
than 3% of the Canadian population aged 12 and over.[137] The CCHS respondents who
consented to share and link their survey information with provincial and federal health
ministries were eligible for linkage. Approximately 84.7% of respondents living outside
of Quebec agreed to share and link their data.[136]

3.1.1.2

Data collection

Before data collection begins for the CCHS, a sample size is calculated to provide
reliable estimates at the provincial and health region (HR) level.[138] It also takes into
account any non-response and vacant or out of scope households.[138] First, the sample
is allocated among provinces proportional to their size and the number of HRs in each
province.[138] Each province's sample is then allocated among its HRs proportionally to
the square root of the population in each HR.[138] Data collection for the CCHS is done
over the telephone or in person, by either computer assisted personal or computer assisted
telephone interviewing techniques.[137] The interview lasts approximately 45
minutes.[137] The CCHS response rate ranged from 73% to 85% during data collection
period of 2001 to 2009.[139,140]
To ensure better coverage of the target population, two sampling frames are used: an area
frame and a telephone frame.[138] The area frame is an adaption of the Canadian Labour
Force Survey which uses a multistage stratified cluster design.[138] The sample is taken
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through a three-stage sampling process (illustrated in Figure 3.1). First, using geographic,
economic, and demographic information, the entire country is divided into strata.[138]
Each stratum is divided into clusters, which is the primary sampling units. The first stage
of the sample process consists of the selection of these clusters within each stratum.[138]
In the second stage of sampling, within each selected cluster, a sample of households is
drawn from a list.[138] The third stage of sampling is the selection of individuals within a
selected household.[138] Either one or two people are selected depending on the
household composition; two persons are selected from large households containing
members in the 12 to 19 years old age group.[138]

Figure 3.1: Illustration of CCHS sampling method
In some HRs, a Random Digit Dialing (RDD) sampling frame or a list frame of telephone
numbers was used. The telephone frame originally consisted of RDD frame of telephone
numbers.[138] This method involved section of working telephone bank (area code and
the first 5 digits of the telephone number).[138] Then numbers from 00 to 99 were
generated at random to create a complete phone number.[138] However, due to low hit
rates, a list frame was used which consisted of a simple list of phone numbers.[141]
Conversely, the disadvantages of the list frame were: confidential and unlisted numbers
were missing, and the list can quickly be outdated as people move. However, it increased
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the hit rates significantly.[141] In the first CCHS cycle, 83% of sample household came
from an area frame. Approximately, 7% of the sample of households came from the RDD
frame, while 10% of the sample was generated from the list frame. This changed to 49%,
50% and 1% of the sample coming from area frame, RDD, and list frame, respectively, in
the following cycles.[142,143]

3.1.2

Discharge Abstract Database

The DAD is a national Canadian database created by the CIHI.[144] This database
includes all separations from hospitals (including discharge, death, sign-outs and transfer)
that occur during a fiscal year (April 1 to March 31).[144] Each abstract includes
information on diagnostic codes, intervention provided and patient demographic and
administrative information.[144] Data from Quebec are not included in the DAD.[144]

3.1.2.1

International Statistical Classification of Diseases and
Related Health Problems

The DAD uses the International Statistical Classification of Diseases and Related Health
Problems (ICD) to report diagnosis. The ICD is a coding system for reporting disease and
health conditions.[144] It was developed by the World Health Organization and was
endorsed by the world health assembly in 1990.[145] The International Classification of
Diseases, 9th Revision, Clinical Modification (ICD-9-CM)[146] and the International
Statistical Classification of Diseases and Related Health Problems, 10th Revision,
Canada (ICD-10-CA) are enhanced version of the 9th and 10th revision of ICD
appropriate for Canadian use.[147] In 2001–2002, the format of the DAD abstract was
changed to accommodate the adoption of the ICD-10-CA classification systems in some
provinces and territories; before which ICD-9-CM was used.[144] The coding system
was updated as the ICD-9 was no longer descriptive enough to precisely reflect the state
of patients’ diseases. For instance, the ICD-9 system had 13,000, three to five-digit codes
and did not have the capacity to expand.[148] The ICD-10 system has 68,000 codes that
are three to seven digits each and has the capacity to expand.[148] Since 2004–2005, all
provinces and territories submitted data to CIHI using the ICD-10-CA abstract.[144]
Table 3.1 shows the implementation year of ICD-10-CA by each province and
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territory.[144] When performing analyses over time or across provinces and territories,
users should note that data element specifications have changed between fiscal years and
appropriate coding scheme should be used.
Table 3.1: The year of Implementation of ICD-10-CA by Province and Territories
Province/
Territory 2001-2002
ICD-10N.L.
CA/CCI
ICD-10P.E.I
CA/CCI
ICD-10N.S.
CA/CCI
ICD-10B.C.
CA/CCI
ICD-10Y.T.
CA/CCI
ICD-10CA/CCI
Sask.
(partial)
Ont.

ICD-9-CM

Alta.

ICD-9-CM

N.W.T.

ICD-9-CM

Nun.

ICD-9-CM

2002-2003
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
(full)
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI

2003-2004
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI

2004-2005
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI

2006-2007
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI

N.B.

ICD-9-CM

ICD-9-CM

ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI

Man.

ICD-9-CM

ICD-9-CM

ICD-9-CM

ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI

ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI
ICD-10CA/CCI

Que.

ICD-9-CCP

ICD-9-CCP

ICD-9-CCP

ICD-9-CCP

The ICD-9-CM diagnosis codes are composed of codes with three, four, or five digits.
The first three digits are included as the heading of a category of codes that may be
further subdivided.[149] Diabetes codes fall under the category 250.[149] The fourth
digit identify complications/manifestations associated with diabetes.[149] See Table 3.2
for details on how diabetes complications/manifestations are categorized in the fourth
digit.[149] A fifth digit is required for all category 250 codes to identify the type of
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diabetes and whether the diabetes is controlled or uncontrolled.[149] See Table 3.3 for
details on the categorization of diabetes types in the fifth digit.[149] Diabetic conditions
can be assigned additional codes for associated conditions. In this case, the code from
category 250 is sequenced before the codes for the associated conditions.[149] Secondary
codes include diabetic retinopathy (362.0) and diabetic macular edema (362.07);
however, these codes are coupled with codes from category 250.[149]
Table 3.2: ICD-9-CM codes for diabetes complications/manifestations
Description
Diabetes without mention of complications
Diabetes with ketoacidosis
Diabetes with hyperosmolarity
Diabetes with other coma
Diabetes with renal manifestations
Diabetes with ophthalmic manifestations
Diabetes with neurological manifestation
Diabetes with peripheral circulatory disorders
Diabetes with other specified manifestations
Diabetes with unspecified complications

ICD-9-CM code
250.0X
250.1X
250.2X
250.3X
250.4X
250.5X
250.6X
250.7X
250.8X
250.9X

Table 3.3: ICD-9-CM codes for type of diabetes
Description
Type 2 diabetes – not stated as uncontrolled
Type 1 diabetes – not stated as uncontrolled
Type 2 diabetes – uncontrolled
Type 1 diabetes – uncontrolled

ICD-9-CM code
250.X0
250.X1
250.X2
250.X3

In general, ICD-10-CA codes can be up to seven characters long and are designed as
follows: XXX.XXX.X (category.anatomic site/severity.extension).[148] The first level of
categorization is the type of diabetes (see Table 3.4).[148] Then the level of control is
indicated by the number after the decimal point.[148] Each numerical code after the
decimal point, numbering 1 through 9, describes a different complication (see Table
3.5).[148] The fifth and sixth characters identify specific types of manifestation.[148]
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Table 3.4: ICD-10-CA codes for type of diabetes
Description
Diabetes mellitus due to underlying condition.
* This code is for diabetes caused by diseases such as
cancer, pancreatitis, or nutritional deficiencies
Drug or chemical induced diabetes mellitus
Type 1 diabetes mellitus
Type 2 diabetes mellitus
Other specified diabetes mellitus.
* This code is for genetic defects of β-cell function and
insulin action or post-pancreatectomy diabetes
Unspecified diabetes

ICD-10-CA code
E08.XXX

E09.XXX
E10.XXX
E11.XXX
E13.XXX

E14.XXX

Table 3.5: ICD-10-CA codes for diabetes complications
Description
Type 2 diabetes with coma
Type 2 diabetes with ketoacidosis
Type 2 diabetes with renal complications
Type 2 diabetes with ophthalmic complications
Type 2 diabetes with neurological complications
Type 2 diabetes with peripheral circulatory complications
Type 2 diabetes with other specified complications
Type 2 diabetes with multiple complications
Type 2 diabetes with unspecified complications
Type 2 diabetes without complications

3.1.2.2

ICD-10-CA code
E11.0XX
E11.1XX
E11.2XX
E11.3XX
E11.4XX
E11.5XX
E11.6XX
E11.7XX
E11.8XX
E11.9XX

Population

Approximately 75% of all hospital separations are represented in the DAD.[144]
Quebec’s hospital separations are submitted to CIHI via Quebec’s ministère de la Santé
et des Services sociaux once per year and is included in the Hospital Morbidity Database
(HMDB), but not in the DAD; this usually accounts for 25% of total hospital
separations.[144] The DAD contains record of hospital activity that is completed for each
event of a hospital separation, meaning that a patient can have multiple records.[144]

3.1.2.3

Data collection

The DAD collection process works as such: first, a patient presents to an acute care
facility, information is then collected on the patient and necessary diagnosis and
interventions are made by the health care team, the information is recorded in the
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institutional health record system, and this information is then submitted to the CIHI
annually.[144] The data goes through quality control measures to ensure that it is in the
expected format, falls within a set range; errors are flagged, and missing data is
represented via blanks or numerical values.[144] Hospitals may be asked to submit
corrections.[144] Every year, enhancements are made to the database to address
emerging health care issues, address client needs, and improve data quality.[144] Support
is provided by the CIHI to assign data collectors with questions related to the DAD
products and provide educational programs on coding and abstracting, how to manage
submission errors and corrections, and other related topics.[144] Adherence to the data
submission and abstracting standards described in the manual helps to ensure that the
DAD reports accurately reflect the institution’s activities.[144] Adherence is obtained
through the application quality control edits, education sessions and ongoing client
support.[144] If data is not received from a particular institution, that institution is
contacted by the CIHI, if necessary.[144]

3.2 Linking the Canadian Community Health Survey to the
Discharge Abstract Database
There are two types of linkage methods: deterministic and probabilistic.[150]
Deterministic linkage is the process of linking datasets using an identifier that is unique
to each participant.[150] There are two possible outcomes of deterministic linkage: 1)
participants who are an exact match are linked, and 2) unmatched participants who do not
get linked.[150] In contrast, probabilistic linkage uses multiple, possibly non-unique,
identifiers to link datasets.[150] Probabilistic record linkage requires the creation of a file
which compares all records in one dataset with those in the other dataset.[150] Following
the linkage, an agreement pattern is determined for each comparison and there may be
partial or full agreement on the identifiers selected for linkage.[150]
The theory of probabilistic record linkage works on the principle that, when two records
are compared, the results of certain agreement patterns are representative of truly linked
pairs, while other agreement patterns are representative of truly unlinked pairs.[150] A
numerical value is assigned to reflect the agreement of the two records, which is derived
using conditional probabilities.[150] For the CCHS-DAD linkage file, which uses
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probabilistic linkage, this numerical value was a weight based on the ratio of the
estimated probability of the outcome occurring for true matches, to the estimated
probability of the outcome occurring for non-matches.[151] Researchers then set a
threshold for determining the linkage status of any two comparisons.[150]
The CCHS records were linked to hospitalization records using probabilistic methods
based on the following common identifiers: date of birth, postal code, sex, province and
Health Insurance Number (HIN).[151] The CCHS file was first linked to the tax data file
(HSTF).[151] This allowed researchers to identify respondents having more than one
postal code during 1996-2012.[151] Eligible CCHS respondents who agreed to share
their data (84.7% = 564,676) were then linked to 49,098,733 hospital records between
April 1, 1999 through March 31, 2013.[151] A total of 1,188,537 hospitalizations were
linked to CCHS respondents. Overall, 57.5% of CCHS respondents were linked to at least
one hospital record.[151]
False Positive Rate (FPR) and False Negative Rate (FNR) were calculated for the
linkage.[151] A clerical review of a probabilistic sample of 4,590 record-pairs was
examined by three independent reviewers.[151] The links are reviewed, and a decision
was made to accept or reject the pair as definitive.[151] For each pair, the review was
based on the comparison of date of birth, postal code, sex, province and HIN.[151] The
final clerical decision was based on the majority vote.[151] The FPR was 0.06% and the
FNR was 2.09%.[151]

3.3 Data setup
The population of interest for this study was individuals who at the time of the CCHS
interview reported no previous diagnosis of T2D, who were 18 years of age and older,
were not pregnant at the time of the interview, resided outside Quebec, and were not
proxy interviews. For the purpose of this project, six cohorts of CCHS respondents who
met the inclusion and exclusion criteria (CCHS 1.1 [2000 to 2001], CCHS 2.1 [2003 to
2004], CCHS 3.1 [2005 to 2006], CCHS 2007, CCHS 2008 and CCHS 2009) were
followed forward in time in the DAD from the date of the CCHS interview. To achieve
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this, each CCHS cohort was linked to subsequent years of DAD files using unique
identifiers provided by Statistics Canada.
Each respondent was followed for three years in the DAD starting from the CCHS
interview date. An assumption was made that if a CCHS respondent reported no
diagnosis of T2D at the time of their CCHS interview and was hospitalized within three
years for a T2D related condition, it is likely they had undiagnosed T2D when the CCHS
interview was conducted. A three-year follow-up period was chosen as the best
compromise between diabetes development and progression, and the longest time we can
assume an individuals had diabetes before diagnosis. Also, the assumption was made that
self-reporting undiagnosed diabetes is an accurate measure of undiagnosed diabetes.
Only the first T2D related hospitalization event was considered for this study. Figure 3.2
illustrates how respondents in the CCHS followed for three years can either have single
hospitalization events (respondents G and I), multiple hospitalization events (respondents
A, C, E, L), or no hospitalization events (respondents B, D, F, J, K). These hospitalization
events can be for different health conditions, including T2D.

Figure 3.2: Illustration of multiple hospitalizations
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A hospitalization event can lead to several diagnoses. For instance, a person might be
hospitalized for a hip fracture (primary diagnosis) might also be diagnosed with T2D and
high blood pressure as a secondary diagnosis. Up to 25 diagnostic codes can be entered
per hospitalization event. For the purpose of this study, a hospitalization with at least one
ICD code for diabetes, appearing as any of the 25 diagnostic codes, was considered a
T2D related hospitalization. Therefore, diabetes might have not be the primary reason for
hospitalization.
Respondents from the province of Quebec were removed. Any CCHS respondents who at
the time of survey reported having diabetes were also removed. Only respondents 18
years of age and older were included in the study. The reason for limiting the study to this
age group is that the effects of health behaviours on health-related outcomes may
manifest differently in adolescents and adults (see objective #3).[152–155] Furthermore,
the population was limited to non-pregnant individuals. CCHS respondents whose data
were collected by proxy interviews were excluded due to a low reliability for questions
regarding health behaviours asked by proxy, as demonstrated in previous research.[156]
Figure 3.3 illustrates the change in sample size of the linked CCHS-DAD datafile as each
criterion was applied.

Initial sample size for each cohort

Multiple hospitalizations removed

2000-2001
2003-2004
2005-2006
2007
2008
2009

2000-2001
2003-2004
2005-2006
2007
2008
2009

n = 273050
n = 251955
n = 250540
n = 126075
n = 127340
n = 108890

n = 117840
n = 112850
n = 113880
n = 57085
n = 62185
n = 52475

Province of Quebec removed

Previous diabetes diagnosis removed

2000-2001
2003-2004
2005-2006
2007
2008
2009

2000-2001
2003-2004
2005-2006
2007
2008
2009

n = 97215
n = 88490
n = 88135
n = 46030
n = 50565
n = 42140

n = 92345
n = 82320
n = 82530
n = 42645
n = 46800
n = 38805
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Age restriction ( >17 years age)

Restricted to non-pregnant

2000-2001
2003-2004
2005-2006
2007
2008
2009

2000-2001
2003-2004
2005-2006
2007
2008
2009

n = 82320
n = 73790
n = 74060
n = 38850
n = 42310
n = 34850

n = 81455
n = 73025
n = 73220
n = 38445
n = 41870
n = 34475

Proxy interviews removed
2000-2001
2003-2004
2005-2006
2007
2008
2009

n = 77055
n = 71750
n = 72215
n = 37720
n = 41100
n = 33880

Male respondents

Female Respondents

2000-2001
2003-2004
2005-2006
2007
2008
2009

2000-2001
2003-2004
2005-2006
2007
2008
2009

n = 34285
n = 32530
n = 32915
n = 16960
n = 18390
n = 15225

n = 42770
n = 39220
n = 39300
n = 20760
n = 22710
n = 18655

Figure 3.3: Inclusion and exclusion criteria – remaining sample size by cohort
As displayed in Figure 3.4, an initial combined sample of 1,137,850 was obtained after
linking the DAD files to each of the six CCHS cohort. As only the first T2D related
hospitalization record was used, this resulted in the removal of 621, 535 records or
54.62% of the sample size. Another 182,595 records were removed due to other
exclusion criteria (see Figure 3.4). A total of 333,720 of the CCHS respondents met the
inclusion criteria (i.e., had no previous diagnosis of T2D, were 18 years or older, were
not pregnant at the time of the interview, resided outside Quebec, were not proxy
interviews, and agreed to share their file between CCHS 1.1 2000/2001 – CCHS 2009).

Initial sample size
for combined
cohort
n = 1137850

Remove multiple
hospitalizations
n = 621535
(54.62%)
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Sample size after
duplicates
removed

Remove Quebec
n = 103740
(20.09%)

n = 516315

Sample size after
Quebec removed

Final sample size
after proxy
removed

Remove previous
diabetes
diagnosis

n = 333720

n = 412575
n = 26180
(6.35%)

Sample size after
diabetics removed
n = 386395

Sample size after
restricting
age

Restrict age

Final sample size
for males

Final sample size
for females

n = 40215
(10.41%)

n = 150305

n = 183415

Remove pregnant
n = 3690 (1.07%)

n = 346180

Sample size after
pregnant
removed

Remove proxy
n = 8770 (2.56%)

n = 342490

Figure 3.4: Inclusion and exclusion criteria – remaining total sample size and
percent removed

3.4 Missing data
Missing data can be divided into three categories. First, values missing completely at
random (MCAR) are not associated with the values of other variables or the missing
values itself.[157] Estimated parameters are not biased by this type of missing
pattern.[157] Second, missing at random (MAR) is the probability that the missing values
are associated with the observed values, but are not related to the specific missing
values.[157] Lastly, missing not at random (MNAR) can bias parameter estimates and
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can occur for two possible reasons: 1) missing values depend on the missing values
itself;[157] for example, people who have higher income are less likely to report it, or 2)
missing values are dependent on other variables;[157] for example, females do not want
to disclose their body weight, therefore, the value of weight is impacted by sex.[157]
Missing values are generated due to non-response to some or all questions in the
CCHS.[158] Some reasons for non-response in the CCHS include refusal to answer some
or all questions, not knowing the answer, and skipping patterns of the questionnaire. In
addition, some questions might be asked in specific years, or they might be asked only of
a specific demographic group.[158] There are two types of non-response: total nonresponse and partial non-response.[158] Total non-response happens when all variables
are missing for a person due to complete refusal to participate in the survey or
interviewers are unable to contact the respondent.[158] This is usually accounted for by
adjusting the sampling weights at Statistics Canada.[158] Partial non-response is when
some values are missing for a participant due to refusal to answer specific questions,
participants not knowing the answers, and unavailability of data due to skipping
patterns.[158]
There are multiple approaches to handling partial non-response. For this study, I utilized
multiple imputation method. In multiple imputation, the missing values are substituted
with a set of plausible values which contain the natural variability of the right value.[159]
Missing data is predicated using observed data and the missing values are replaced with
the predicted value.[159] This process is repeated multiple times creating multiple
datasets. Each dataset is analyzed separately using standard statistical procedures. The
analysis results are then combined to produce a single overall estimate.[159] For this
study, 20 imputations were conducted in order to achieve more consistent estimates and
standard errors.[160]

3.5 Measurement
The outcome variable for this study was T2D related hospitalizations. A number of
explanatory variables were selected as potential predictors of T2D related hospitalization
based on previous literature and availability of information in the CCHS. The explanatory
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variables selected for comparisons are as follows: age, visible minority, marital status,
education, income, household size, rurality, BMI, self-reported health, having a regular
doctor, visiting doctor in past 12 months, alcohol drinking, smoking tobacco, physical
activity, and fruits and vegetable consumption. The explanatory variables were broken
down into three groups: sociodemographic, health-related and behavioural predictors.
Some categorical variables were collapsed to binary variables. Lastly, survey design
variables (mode of interview, year of interview) were used to adjust for differing survey
conditions.

3.5.1

Outcome variable – type 2 diabetes related hospitalization

To ascertain T2D related hospitalization amongst individuals with unreported T2D, the
population of interest was followed in the DAD for three years following their interview
date. If a diagnosis code for T2D (primary or secondary) occurred during the three-year
follow-up period, respondents were coded as having T2D related hospitalization. If
respondents were not hospitalized or were hospitalized for other conditions, they were
coded as not having T2D related hospitalization.
The diagnosis codes were based on the ICD-9-CM and ICD-10-CA for T2D due to
changes in diagnosis coding in the DAD over time. For ICD-9-CM, category 250.X0 and
250.X2 (X = 0 through 9) were selected. For ICD-10-CA, E11.XXX.X (with any
anatomic site/severity and extension) were selected. All diagnoses, up to 25 diagnostic
codes per hospitalization event, were considered.

3.5.2

Sex

Sex is a binary variable in the CCHS. Interviewers entered in the sex of the respondent
during initiation of the interview. If necessary, interviewer asked the sex of the
participants. This is coded as male and female. No missing values were observed for this
variable. The analyses were stratified by sex.

3.5.3

Sociodemographic predictors

Sociodemographic variables include age, visible minority, marital status, education,
income, household size and rurality. These variables have been previously linked to T2D
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or T2D related hospitalization among individuals diagnosed with T2D. For example, the
proportion of patients hospitalized for T2D related complications has been shown to
increase with age.[118] Furthermore, there is evidence to suggest the adjusted odds of
hospitalization for both males and females followed a parabolic path.[122] Additionally,
non-white individuals[122] and non-married individuals have been found to have higher
T2D related hospitalizations.[161] Individuals in the lowest income and education
quintile are more likely to have an a T2D hospitalization event than those in the highest
quintile.[120] Household size was included to reflect how many individuals in the
household depend on the income.[162] Lastly, living in rural areas has also shown to
affect hospitalization events.[44]

3.5.3.1

Age

Age is a continuous variable and is based on the CCHS respondents date of birth. For the
purpose of this study, age was centered at 18 and coded into deciles. The age variable
was squared and used in the regression model as a quadratic predictor alongside a linear
age variable. No missing values were observed for this variable.

3.5.3.2

Visible minority

In the CCHS, two questions are asked to determine the respondent's visible minority
status. First respondents are asked, “Are you an Aboriginal person, that is, First Nations,
Métis or Inuk (Inuit)?”. Non-aboriginal respondents are further asked to classify
themselves as part of one or more racial or cultural groups on the following list: White,
South Asian (e.g., East Indian, Pakistani, Sri Lankan etc.), Chinese, Black, Filipino, Latin
American, Arab, Southeast Asian (e.g., Vietnamese, Cambodian, Malaysian, Laotian,
etc.), West Asian (e.g., Iranian, Afghan, etc.), Korean and Japanese. For the purpose of
this study, a binary variable was created. One group was classified as white and visible
minority, including Aboriginal, were grouped as non-white. Non-respondents were coded
as missing to be imputed.
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3.5.3.3

Marital status

Marital status is a categorical variable in the CCHS. Respondents were asked to classify
themselves into one of the six categories: married, common-law, widowed, separated,
divorced and single and never married. For the purpose of this study, this variable was
dichotomized. Married and common-law were grouped together as married. Widowed,
separated, and divorced were group as not married. No missing values were observed for
this variable.

3.5.3.4

Education

The following question was used to determine the level of education achieved by the
CCHS respondents: “what is the highest degree, certificate or diploma you have
obtained?” Possible answers included: Less than secondary school graduation, secondary
school graduation, some post-secondary, post-secondary and graduate. For the purpose
of this study, a dichotomous variable was created with the following categories: less than
secondary school and secondary school or more. Non-response was coded as missing to
be imputed.

3.5.3.5

Income

Income was a derived variable based on respondents answer to the question: “What is
your best estimate of the total income, before taxes and deductions, of all household
members from all sources in the past 12 months?”. If respondents did not answer the
question, they were asked to estimate which of the following groups their household
income fell into: less than $5,000 or $5,000 or more, less than $10,000 or $10,000 or
more, less than $15,000 or $15,000 or more, less than $20,000 or $20,000 or more, less
than $30,000 or $30,000 or more, less than $40,000 or $40,000 or more, less than
$50,000, $50,000 to less than $60,000, $60,000 to less than $80,000, $80,000 to less than
$100,000, and $100,000 or more.
The CCHS categorized total household income from the above questions. Possible
categorizations in CCHS 1.1 were no income, less than $5000, $5000 to $9999, $10,000
to $14,999, $15,000 to $19,999, $20,000 to $29,999, $30,000 to $39,000, $40,000 to

41

$49,000, $50,000 to $59,999, $60,000 to $79,999 and $80,000 or more. However, the
categories were expanded over time to include $60,000 to $69,000, $70,000 to $79,999,
$80,000 to $89,999, $90,000 to $99,999, $100,000 to $149,999 and $150,000 or more.
For the purpose of keeping this variable consistent throughout the survey collection
period, the categorizations were standardized to the CCHS 1.1. Non-response to this
variable was coded as missing for imputation.

3.5.3.6

Household size

The CCHS includes variable that indicates the number of people living within a
household. This variable was a continuous variable with values ranging from 1 to 28.
This variable was recoded to include one, two, three, four, five, six or more. There were
no missing values on this variable.

3.5.3.7

Rurality

Respondents in the CCHS were categorized into rural or urban based on their postal
code. The CCHS described an urban area as continuously built-up and not having
discontinuity exceeding two kilometers. Urban areas were also categorized as having a
population concentration of 1,000 or more and a population density of 400 or more per
square kilometer. This was based on the most recent census information.[163] This
variable did not have any missing information

3.5.4

Health-related predictors

These predictors include BMI and self-reported health. There has a been a strong
association found between BMI and T2D. Hospitalizations related to T2D have also been
linked to BMI.[118] Furthermore, T2D can be linked to several other health conditions,
with worse health status predicting hospitalization events.[123]

3.5.4.1

Body mass index

In order to derive BMI, the height and weight of the participants was used. In the CCHS,
respondents are asked to disclose their height and weight. These values can be expressed
in either inches or centimeter and pounds or kilograms. All values are converted to metric
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units by CCHS. The following formula was used to calculate respondents’ BMI:
BMI=kg/m^2. Any missing values for height or weight generated missing value for BMI.
This was flagged as missing for imputation purposes.

3.5.4.2

Self-perceived health

Respondents were asked, “In general, would you say your health is excellent, very good,
good, fair, or poor?”. A binary variable was created with excellent, very good, good
categorized as good and fair or poor categorized into poor. Respondents who did not
answer this question were flagged and missing values were imputed

3.5.5

Behavioural predictors

Behavioural predictors include having a regular doctor, visiting doctor in past 12 months,
alcohol drinking, smoking tobacco, physical activity, and fruits and vegetable
consumption. These variables have previously been linked to T2D and T2D
hospitalization. Increased use of primary care among T2D patients has been associated
with increased risk of a subsequent hospitalization.[128] Primary care use has also been
associated with T2D hospitalizations.[123] An increased risk of hospital admissions in
smokers and physically inactive participants has been found.[129] In contrast, regular
alcohol drinkers have been shown to have lower hospitalization rates than did occasional
or non-drinkers.[123] Lastly, eating a diet high in fruits and vegetables has been
associated with lower hospitalization rates for T2D.[164]

3.5.5.1

Having a regular doctor

All respondents in the CCHS were asked, “Do you have a regular medical doctor?”
Respondents could answer yes or no. Respondents who did not know the answer or
refused to answer were flagged as missing for imputation.

3.5.5.2

Visiting doctor in past 12 months

The CCHS asks respondents, “During the past 12 months, how many times have you seen
or talked to on the telephone, about your physical, emotional or mental health with a
family doctor or a general practitioner?” Responses ranged from 0 to 366. For the
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purpose of this study, this variable was categorized in to visited doctor in past 12 months
and did not visit doctor in the past 12 months. Non-responses to this question were
flagged as missing for imputation.

3.5.5.3

Alcohol drinking

In the CCHS, respondents were asked the following questions about their drinking
history: “have you ever had a drink?”; “have you drank in the past 12 months?”; and if
so, “during the past 12 months, how often did you drink alcoholic beverages?” This
information was used to derive a categorical variable that groups respondents into the
following drinking categories: regular drinker, occasional drinker and former drinker,
and never drank. Regular drinkers are defined as anyone who drinks at least once a
month. Occasional drinkers are defined as individuals who drink less than once a month.
Former drinkers consist of individuals who drank in their lifetime but not in the past 12
months. Lastly, never drank is defined as individuals who have not consumed alcoholic
beverages in their lifetime.
For the purpose of this study, a binary variable was created. Regular drinkers and
occasional drinkers were grouped as current drinkers. Former drinkers and never drank
were grouped as currently non-drinkers. Respondents who did not answer were flagged
as missing for imputation.

3.5.5.4

Smoking tobacco

In the CCHS, respondents were asked the following questions: 1) “In your lifetime, have
you smoked a total of 100 or more cigarettes?”; 2) “Have you ever smoked a whole
cigarette?”; 3) “At the present time do you smoke cigarettes daily, occasionally or not at
all?; 4) “Have you ever smoked cigarettes daily?” Based on smoking habits, respondents
were categorized into the following 7 categories: daily smokers, occasionally but former
daily smoker, always occasional smoker, former daily smoker non-smoker now, former
occasional smoker nonsmoker now and never smoked.
A dichotomous variable was created for the purpose of this study. Daily, occasionally but
former daily smoker, and always occasional smoker were grouped together as current
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smokers whereas former daily smoker non-smoker now, former occasional smoker nonsmoker now, and never smoked were grouped together as currently non-smokers.
Respondents who did not answer were flagged as missing.

3.5.5.5

Physical activity

Physical activity was measured using participants’ self-reported frequency and duration
of leisure physical activity within the three months prior to survey administration. In the
CCHS, each type of physical activity (e.g., swimming, biking) was assigned a
corresponding Metabolic Equivalent (MET) value - multiple of resting metabolic rate.
For example, a MET value of 2 indicates twice the energy expended compared to rest.
The volume of physical activity was calculated by multiplying the frequency and duration
of each type of physical activity as well as the MET value of the activity to derive how
much energy was expended daily. Higher MET values indicate higher volume of physical
activity. Respondents who did not answer were flagged as missing for imputation.

3.5.5.6

Fruits and vegetable consumptions

Total fruit and vegetable consumption was based on responses to a series of questions
regarding the frequency of consumption of specific types of fruits and vegetables.
Participants were asked the following questions: “how often do you drink fruit juices
such as orange, grapefruit or tomato?”; “how often do you usually eat fruit?”; “how often
do you eat green salad?”; “how often do you eat potatoes, not including french-fries, fried
potatoes, or potato chips?”; “how often do you usually eat carrots?”; “how many servings
of other vegetables do you usually eat, not counting carrots, potatoes, or salad?”
Participants could report on per day, per week, or per month bases. Average daily
frequency of fruit and vegetable consumption was calculated for each participant as a
continuous measure by first converting the numerical responses into average daily
consumption and then adding the responses to the six questions. Respondents who did not
answer were flagged as missing.
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3.5.6

Survey design variables

Survey design variables included the year of the CCHS interview and mode of interview.
As prevalence of T2D, management of T2D and polices around health care changed over
time in Canada, it is important to consider how the year of data collection can impact
T2D related hospitalizations. Additionally, when comparing two modes of interviewing,
in-person interviews to telephone interviews, significant differences were found between
two modes of interviews for some health indicators.[165] For example, obesity was
significantly higher for in-person interviews (17.9%) than for telephone interviews
(13.2%).[165]

3.5.6.1

Interview date

The CCHS records the date of the CCHS interview; this includes the day, month and
year. A new variable was created, year of interview, to represent the year of the data
collection ranging from 2000 to 2009. This variable was further centered at the year
2000, the first year of data collection for the first CCHS cohort, which results in the range
of 0 to 9. The purpose for centering the variable at 2000 was so the intercept term in the
regression model can be interpreted as the log-odds of T2D related hospitalization when
the year of data collection is 2000.

3.5.6.2

Mode of interview

Mode of interview is a binary variable in the CCHS with in-person interview and
telephone interview as the two options. Missing information on this variable was flagged
for imputation

3.6 Statistical analysis
This study employed sex gender-based analysis (SGBA),[166] an approach that examines
diversity between males and females with the goal of contributing to more
comprehensive knowledge that addresses differences between women and men. Male and
female bodies have innate physiological differences that may contribute to the
relationship between explanatory variables and T2D related hospitalization

46

differently.[167] There is research to suggest T2D related hospitalization rate differ
between men and women.[33]

3.6.1

Descriptive statistics

Descriptive statistics were produced for both missing and imputed datasets to understand
the basic characteristics of the combined six CCHS cohorts. The SURVEYFREQ
procedure in SAS was used to produce population estimates and frequencies from survey
data. This procedure utilizes bootstrap weights to takes into account the survey design to
compute variance and confidence intervals.[168] The SURVEYFREQ procedure in SAS
was used to compute a frequencies distribution table with 95% confidence intervals for
nominal and ordinal variables. Frequency distribution was computed for the following
categorical variables: mode of interview, visible minority, marital status, education,
income, household size, rurality, self-reported health, having a regular doctor, visiting
doctor in past 12 months, alcohol drinking, and smoking tobacco. The SURVEYMEANS
procedure in SAS was used to produce population estimates means, standard deviation
and corresponding 95% confidence interval (CI) for continuous variables. This procedure
also estimates variance and confidence intervals taking into account the survey
design.[169] Means and standard deviations were generated for the following variables:
age, income, household size, BMI, physical activity, and fruits and vegetable
consumption.

3.6.2

Analysis for objective 1

The first objective is to identify the percentage of men and women in Canada with
unreported T2D who experience a T2D related hospitalization. Using SURVEYFREQ
procedures, a frequency distribution table was created for the outcome variable T2D
related hospitalization separately for males and female. Results were generated by
pooling respondents from the six CCHS cohorts. This estimated the average percentage
of T2D related hospitalization and corresponding confidence intervals between 2000 and
2009.
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3.6.3

Analysis for objective 2

The second objective was to explore temporal trends of T2D related hospitalizations
among Canadian men and women with unreported T2D. First, SURVEYFREQ
procedures was used to produce percent of T2D related hospitalizations with
corresponding confidence intervals for each year the CCHS survey was conducted. A bar
graph was produced for the percentage of T2D related hospitalization in each year.
Second, SURVEYLOGISTIC procedure was used to model the log-odds of T2D related
hospitalizations based on the year of respondents’ interviews. PROC
SURVEYLOGISTIC fits linear logistic regression models for categorical response by the
method of maximum likelihood. SURVEYLOGISTIC incorporates complex survey
designs, including designs with stratification, clustering, and unequal weighting by using
bootstrap weights.

3.6.4

Analysis for objective 3

The third objective was to explore the role of sociodemographic, health and behavioral
risk factors associated with T2D related hospitalization among Canadian men and women
with unreported T2D. Using SURVEYLOGISTIC, a linear logistic regression model was
produced for males and females separately using the imputed datasets. The outcome
variable was T2D related hospitalization and the explanatory variables were age, marital
status, visible minority, education, income, household size, rurality, BMI, self-reported
health, having a regular doctor, visiting doctor in past 12 months, alcohol drinking,
smoking tobacco, physical activity, and fruit and vegetable consumption. Mode of
interview and year of interview were included in the model to control for survey
conditions. MIANALYZE was used to pool the results of each estimates from each
imputed dataset. Odds ratios and confidence intervals were computed. Statistical
significance was defined as a p-value < 0.05.
Mode of interview, visible minority, marital status, education, rurality, self-reported
health, having a regular doctor, visiting doctor in past 12 months, alcohol drinking and
smoking tobacco were treated as categorical variables in the logistics regression model.
The reference groups are presented in Table 3.5. Whereas age, income, household size,
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BMI, physical activity, and fruits and vegetable consumption were treated as continuous
variables.
Table 3.6: Reference group for categorical variables
Variables
Type of interview
Visible minority
Marital status
Education
Rurality
Self-reported health
Having a regular doctor
Visit doctor in past 12 months
Alcohol drinking
Smoking tobacco

3.6.5

Reference Group
Telephone Interview
White
Not married
Less than secondary
Urban
Good
No
No
currently non-drinker
currently non-smoker

Sampling weights

The sample weight corresponds to the number of people in the population that are
represented by each CCHS respondent. Standardized sample weights were applied to all
statistical tests in order for the estimates produced by this study to be representative of
Canadian population. Sampling probability differ between regions; therefore, weights are
different from one person to another.[170]

3.6.6

Bootstrap weights

To ensure that results from the analysis of the CCHS data take into account complex
design, bootstrap weights were used. The bootstrap method consisted of subsampling the
initial CCHS sample and they were generated at statistics Canada. A simple random
sample was selected, with replacement, from n-1 clusters within the n clusters of the
stratum. The process was repeated 500 times, creating 500 new subsamples. Weights
were recalculated for each of the 500 samples called the bootstrap weights. The bootstrap
weights were used to calculate 500 estimates which are then used to estimate the
variance.[171]

3.6.7

Statistical software

All statistical analyses were completed using SAS software version 9.4.[172]
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Chapter 4

4

Results

This chapter will present the study findings. First, this chapter will summarize the
missing data patterns for variables of interest. Then it will provide a description of the
study sample. Following that, the results for objective 1, objective 2 and objective 3 will
be presented.

4.1 Descriptive statistics
Of the CCHS respondents included in the study, 45.04% (150,305 respondents) were
male and 54.96% (183,415 respondents) were female. Overall, 79% of respondents had
complete data with no missing values for any of the variables included in this study.
Table 4.1 outlines the missing data pattern for males and females. Percentage of missing
values was generally low for most variables, with less than 1% missing. Income and fruit
and vegetable consumption had the highest missing percentage; 8.77% and 9.67%,
respectively, for males and 12.32% and 9.45%, respectively, for females. Missing
patterns were similar between males and females except for BMI and smoking status.
Female respondents had higher percentage of missing values for BMI compared to males
(3.27% vs. 0.66%). Whereas men had higher percentage of missing values for the
smoking variable (0.46% vs. 0.14%). When the descriptive statistics for the datasets with
missing values and the imputed values are compared, the estimates are similar.
Table 4.1: Descriptive statistics for dataset with missing values

Variables
Mode of interview
Telephone
In person
Age
Visible minority
White

Male ( n = 150,305 )
Percent/
95% Confidence
Mean(SD)
Interval
61.47
60.60
62.34
38.53
37.66
39.40
Percent missing = 0.10
43.81
43.74
43.89
(16.42)
80.53

80.01

81.04

Female ( n = 183,415 )
Percent/
95% Confidence
Mean(SD)
Interval
61.12
60.21
62.02
38.88
37.98
39.79
Percent missing = 0.11
45.6 (17.26)

45.52

45.68

80.96

80.52

81.40
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Non-white
Marital status
Not married
Married
Education
Less than secondary
school
Secondary school or
more
Income
No Income
Less than $5,000
$5,000 - $9,999
$10,000 - $14,999
$15,000 - $19,999
$20,000 - $29,999
$30,000 - $39,999
$40,000 - $49,999
$50,000 - $59,999
$60,000 - $79,999
$80,000 Or More
Mean Income
Household size
1
2
3
4
5
6
Mean Household Size
Rurality
Urban
Rural
BMI
Self-reported health
Poor
Good

19.47
18.96
19.99
Percent missing = 0.56

19.04
18.60
19.48
Percent missing = 0.49

34.09
33.59
34.60
65.91
65.40
66.41
Percent missing = 0.10

37.52
37.13
37.91
62.48
62.09
62.87
Percent missing = 0.13

14.60

14.32

14.87

14.46

14.21

14.71

85.40

85.13

85.68

85.54

85.29

85.79

Percent missing = 1.08

Percent missing = 0.91

0.34
0.27
0.40
0.51
0.45
0.58
0.99
0.90
1.08
2.37
2.24
2.50
2.41
2.29
2.54
6.91
6.69
7.14
8.61
8.37
8.86
8.89
8.63
9.14
9.14
8.89
9.39
17.53
17.15
17.90
42.29
41.80
42.78
8.22 (2.13)
8.19
8.24
Percent missing = 8.77

0.27
0.22
0.31
0.57
0.52
0.62
1.49
1.39
1.58
4.26
4.12
4.41
4.35
4.20
4.51
9.66
9.42
9.89
10.26
10.00
10.52
9.45
9.21
9.69
9.31
9.06
9.56
16.49
16.15
16.83
33.89
33.44
34.34
7.72 (2.31)
7.70
7.74
Percent missing = 12.32

12.07
32.80
19.49
21.73
9.16
4.75
2.97 (1.35)

14.50
33.65
18.47
20.16
8.89
4.44
2.89 (1.36)

11.57
32.20
19.10
21.14
8.79
4.43
2.94

12.58
33.39
19.88
22.32
9.52
5.08
3.01

82.06
81.70
82.42
17.94
17.58
18.30
26.37 (4.42) 26.34
26.41
Percent missing = 0.66
9.48
90.52

9.23
90.28

9.72
90.77

14.01
33.04
18.08
19.67
8.51
4.16
2.86

14.96
34.18
18.83
20.61
9.25
4.71
2.91

82.93
82.61
83.25
17.07
16.75
17.39
25.06 (5.20) 25.02
25.10
Percent missing = 3.27
11.19
88.81

10.92
88.54

11.46
89.08
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Percent missing = 0.07
Having a regular
doctor
No
Yes
Visit doctor in past 12
months
No
Yes
Alcohol drinking
Currently non-drinker
Currently drinker
Smoking tobacco
Currently non-smoker
Currently smoker
Physical Activity
Fruit and vegetable
consumption

Percent missing = 0.08

16.16
15.83
16.48
83.84
83.52
84.17
Percent missing = 0.05

8.42
8.20
8.65
91.58
91.35
91.80
Percent missing = 0.03

27.07
26.66
27.47
72.93
72.53
73.35
Percent missing = 0.21

14.67
14.37
14.97
85.33
85.03
85.63
Percent missing = 0.42

14.35
14.01
14.69
85.65
85.31
86.00
Percent missing = 0.46

22.88
22.48
23.28
77.12
76.72
77.52
Percent missing = 0.42

73.65
73.24
74.06
26.35
25.94
26.76
Percent missing = 0.46
2.31 (2.44)
2.28
2.33
Percent missing = 0.13

79.47
79.16
79.79
20.53
20.21
20.84
Percent missing = 0.14
1.94 (1.94)
1.93
1.96
Percent missing = 0.08

4.43 (2.55)

5.11 (2.64)

4.40

4.45

Percent missing = 9.67

5.08

Percent missing = 9.45

Note: Proportion and confidence interval are presented for categorical variables: mode of interview, visible
minority, marital status, education, income, household size, rurality, self-reported health, having a regular
doctor, visiting doctor in past 12 months, alcohol drinking and smoking tobacco. Mean and standard
deviation (SD) with corresponding confidence intervals are presented for continuous variables: age,
income, household size, BMI, physical activity, and fruits and vegetable consumption.

Table 4.2 summarizes the descriptive statistics for the imputed data. The mean age was
43.81 (SD=16.42) and 45.60 (SD=17.26) for males and females, respectively.
Approximately 19% of males and females reported being visible minority, 65.90% of
males and 62.47% of females reported being married, and approximately 14.60% of
males and 14.46% of females reported having less than secondary schooling. A higher
percentage of men reported an income of $80,000 or more compared to women (41.34%
vs. 32.52). The mean income for men ($50,000-$79,999) was higher than women
($40,000-$59,999). Household size was similarly distributed between men and women
with majority of household comprising of 1 to 4 people. The majority of people lived in
urban centers (~82%).
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Upon examining the health-related predictors, the mean BMI reported by men was 26.37
(SD=4.42). The mean BMI reported by women was slightly lower at 25.08 (SD=5.20).
For self-report health, 9.48% of men and a slightly higher percentage of women (11.20%)
reported having poor health.
For the behavioural predictors, 83.84% of men and 91.58% of women reported having
regular doctors, and 72.99% of men and 85.10% of women reported visiting a doctor in
the past 12 months. A higher percentage of men reported being current drinkers
compared to women (85.62% vs. 77.70%). Additionally, a higher percentage of men
reported being current smokers compared to women (26.34 vs. 20.53). Men had higher
levels of physical activity compared to women; mean MET for men was 2.31 (SD=2.44),
whereas, mean MET for women was 1.95 (SD=2.04). Lastly, women reported a higher
percentage of fruit and vegetable consumption; mean fruit and vegetable consumption for
females was 5.11 (SD=2.57) and mean fruit and vegetable consumption for men was 4.43
(SD=2.28).
Table 4.2: Descriptive statistics for dataset with imputed values

Variables
Mode of Interview
Telephone
In person
Age
Visible minority
White
Non-white
Marital status
Not married
Married
Education
Less than secondary
school
Secondary school or
more
Income

Male ( n = 150,305 )
Percent/
95% Confidence
Mean(SD)
Interval
61.48
38.52
43.81
(16.42)

60.61
37.65

62.35
39.39

43.74

43.89

80.53
19.47

80.02
18.96

34.10
65.90

Female ( n = 183,415 )
Percent/
95% Confidence
Mean(SD)
Interval
61.12
38.88
45.60
(17.26)

60.22
37.97

62.03
39.78

45.52

45.68

81.04
19.98

80.97
19.03

80.53
18.60

81.40
19.47

33.60
65.40

34.60
66.40

37.53
62.47

37.14
62.09

37.91
62.86

14.66

14.38

14.93

14.53

14.28

14.78

85.34

85.07

85.62

85.47

85.22

85.72
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No Income
0.31
Less Than $5,000
0.49
$5,000 - $9,999
0.97
$10,000 - $14,999
2.45
$15,000 - $19,999
2.54
$20,000 - $29,999
7.14
$30,000 - $39,999
8.87
$40,000 - $49,999
9.05
$50,000 - $59,999
9.30
$60,000 - $79,999
17.55
$80,000 Or More
41.34
Mean Income
8.18 (2.17)
Household size
1
12.07
2
32.80
3
19.49
4
21.73
5
9.16
6
4.75
Mean Household size 2.98 (1.35)
Rurality
Urban
82.06
Rural
17.94
BMI
26.37 (4.42)
Self-reported health
Poor
9.48
Good
90.52
Having a regular
doctor
No
16.16
Yes
83.84
Visit doctor in past
12 months
No
27.01
Yes
72.99
Alcohol drinking
Currently non-drinker
14.38
Currently drinker
85.62
Smoking
Currently non-smoker
73.66
Currently smoker
26.34
Physical activity
2.31 (2.44)

0.25
0.43
0.90
2.34
2.43
6.93
8.65
8.83
9.08
17.21
40.89
8.17

0.36
0.55
1.05
2.56
2.65
7.34
9.09
9.27
9.52
17.88
41.79
8.19

0.26
0.57
1.53
4.42
4.50
10.02
10.62
9.70
9.44
16.41
32.52
7.66 (2.36)

0.22
0.53
1.45
4.29
4.37
9.82
10.40
9.49
9.23
16.11
32.13
7.64

0.30
0.62
1.62
4.55
4.64
10.22
10.84
9.90
9.66
16.71
32.90
7.68

11.57
32.20
19.10
21.14
8.79
4.43
2.95

12.58
33.39
19.88
22.32
9.52
5.08
3.01

14.48
33.61
18.45
20.14
8.88
4.43
2.89 (1.36)

14.01
33.04
18.08
19.67
8.51
4.16
2.86

14.96
34.18
18.83
20.61
9.25
4.71
2.92

81.70
17.58
26.34

82.42
18.30
26.41

82.93
17.07
25.08 (5.20)

82.61
16.75
25.04

83.25
17.39
25.12

9.23
90.27

9.73
90.77

11.20
88.80

10.93
88.53

11.47
89.07

15.84
83.52

16.48
84.16

8.42
91.58

8.20
91.35

8.65
91.80

26.60
72.58

27.42
73.40

14.60
85.40

14.30
85.10

14.90
85.70

14.04
85.28

14.72
85.96

22.90
77.10

22.50
76.70

23.30
77.50

73.25
25.94
2.28

74.06
26.75
2.33

79.47
20.53
1.95 (2.04)

79.16
20.21
1.93

79.79
20.84
1.96
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Fruit and vegetable
consumption

4.43 (2.48)

4.40

4.45

5.11 (2.57)

5.08

5.13

Note: Proportion and confidence interval are presented for categorical variables: mode of interview, visible
minority, marital status, education, income, household size, rurality, self-reported health, having a regular
doctor, visiting doctor in past 12 months, alcohol drinking and smoking. Mean and standard deviation (SD)
with corresponding confidence intervals are presented for continuous variables: age, income, household
size, BMI, physical activity, and fruits and vegetable consumption.

4.2 Objective 1
Among Canadian adults with unreported T2D, 0.56% (95% CI=0.49%, 0.63%) of men
and 0.44% (95% CI=0.39%, 0.48%) of women experienced a hospitalization event
related to T2D during 2000-2009. That is 840 men and 800 women who were
hospitalized for T2D up to three years following the CCHS interview but reported no
previous diagnosis of diabetes. The percentage hospitalization event related to T2D was
higher among men than in women.
Table 4.3: Percentage of type 2 diabetes related hospitalization among adults with
unreported diabetes

T2D related hospitalization
No
Yes

Male (n = 150,305)
95% Confidence
Percent
Interval
99.44
99.37
99.51
0.56
0.49
0.63

Female (n = 183,415)
95% Confidence
Percent
Interval
99.56
99.52
99.61
0.44
0.39
0.48

4.3 Objective 2
Among Canadian adults with unreported T2D, 0.44% (95% CI=0.27%, 0.55%) of men
and 0.33% (95% CI=0.23%, 0.43%) of women experienced a hospitalization event
related to T2D in 2000. Among men, an increase in the percentage of T2D related
hospitalizations was observed in 2001 (0.47%; 95% CI=0.36%, 0.59%). Hospitalizations
declined in 2003 to 0.43% (95% CI=0.34%, 0.50%); however, the percentage of men
experiencing T2D related hospitalization steadily increased after that: 0.49% (95%
CI=0.57%, 0.99%) in 2005; 0.55% (95% CI=0.42%, 0.67%) in 2007; 0.65% (95%
CI=0.42%, 0.88%) in 2008; 0.77% (95% CI=0.54%, 0.99%) in 2009. In contrast, among
women, an increase in the percentage of T2D related hospitalization was observed till
2005 (0.52%; 95% CI=0.42%, 0.63%). However, the percentage declines to 0.37% (95%
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CI=0.27%, 0.47%) in 2007. A further increase was observed after that: 0.40% (95%
CI=0.25%, 0.50%) in 2008; 0.55% (95% CI=0.41%, 0.68%) in 2009. (Table 4.4)
Table 4.4: Temporal trend in percentage of type 2 diabetes related hospitalization
between 2000 to 2009 among adults with unreported type 2 diabetes
Year of
Interview
2000
2001
2003
2005
2007
2008
2009

Male ( n = 150305 )
95% Confidence
Percent
Interval
0.41
0.27
0.55
0.47
0.36
0.59
0.43
0.34
0.50
0.49
0.40
0.57
0.55
0.42
0.67
0.65
0.42
0.88
0.77
0.54
0.99

Female ( n = 183415 )
95% Confidence
Percent
Interval
0.33
0.23
0.43
0.37
0.28
0.45
0.42
0.33
0.49
0.52
0.42
0.63
0.37
0.27
0.47
0.40
0.28
0.50
0.55
0.41
0.68

Figure 4.1 and Figure 4.2 illustrate the change in percentage of T2D related
hospitalization among men and women with unreported T2D, respectively. The linear
trend was tested and showed that men had higher odds of T2D related hospitalization
between 2000 and 2009 (OR=1.07, CI=1.03, 1.12). This annual positive trend was a
statistically significant (p=0.0004). For women, however, the linear trend in T2D related
hospitalization was not statistically significant (p=0.0987; OR=1.03, CI=0.99, 1.06).
Refer to Table 4.5 for the results of the linear trend test using logistic regression.
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Figure 4.1: Temporal trends in percentage of type 2 diabetes related hospitalization
between 2000 to 2009 among males with unreported type 2 diabetes

57

PERCENTAGE OF T2D HOSPITALIZATION

0.8
0.7
0.6
0.5
0.4
0.3
0.2

0.1
0
2000

2001

2003

2005

2007

2008

2009

YEAR OF INTERVIEW

Figure 4.2: Temporal trends in percentage of type 2 diabetes related hospitalization
between 2000 to 2009 among females with unreported diabetes
Table 4.5: Test of linear trend for type 2 diabetes related hospitalization between
2000 to 2009 among adults with unreported type 2 diabetes
Male ( n = 150305 )
Effect

Odds
ratio

Date of
Interview

1.07

95% Confidence
interval
1.03

1.12

p-value
0.0004*

Female ( n = 183415 )
95%
Odds
Confidence
p-value
ratio
interval
1.03

0.99

1.06

0.0987

Note: * denotes significances at alpha=0.05

4.4 Objective 3
Examination of the cross tabulation of sociodemographic, health-related, and behavioural
predictors (see Table 4.6) reveals that a higher percentage of white males (0.59%, 95%
CI= 0.53%, 0.66%) and white females (0.46%, 95% CI= 0.41%, 0.51%) with unreported
T2D were hospitalized for T2D between 2000 to 2009 compared to non-white males and
females (0.59%, 95% CI= 0.53%, 0.66% and 0.59%, 95% CI= 0.53%, 0.66%,
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respectively). A higher percentage of married men reported T2D related hospitalization
compared to non-married men (0.42%, 95% CI= 0.36%, 0.49% and 0.63%, 95% CI=
0.54%, 0.72%, respectively). In contrast, women who were not married reported a higher
percentage of T2D related hospitalization compared to married women (0.53%, 95% CI=
0.46%, 0.60% and 0.38%, 95% CI= 0.33%, 0.43%, respectively). Both men and women
who had less than secondary education reported higher percentage of T2D related
hospitalization (1.13%, 95% CI= 0.97%, 1.29% and 1.09%, 95% CI= 0.93%, 1.24%,
respectively) compared to men and women who had secondary school or more (0.46%,
95% CI= 0.39%, 0.53% and 0.32%, 95% CI= 0.28%, 0.36%, respectively). Both men and
women who lived in a rural area reported higher percentage of T2D related
hospitalization (0.53%, 95% CI= 0.46%, 0.61% and 0.41%, 95% CI= 0.37%, 0.46%,
respectively) compared to men and women who lived in urban area (0.67%, 95% CI=
0.55%, 0.79% and 0.55%, 95% CI= 0.45%, 0.64%, respectively). Men and women who
reported poor health reported much higher percentage of T2D related hospitalizations
(1.95%, 95% CI= 1.67%, 1.24% and 1.28%, 95% CI= 1.10%, 1.47%, respectively)
compared to men and women who reported good health (0.41%, 95% CI= 0.35%, 0.48%
and 0.33%, 95% CI= 0.29%, 0.37%, respectively). Furthermore, both men and women
who reported having a regular doctor reported a higher percentage of T2D related
hospitalizations (0.63%, 95% CI= 0.56%, 0.71% and 0.46%, 95% CI= 0.41%, 0.50%,
respectively) compared to men and women who did not have a regular medical doctor
(0.17%, 95% CI= 0.12%, 0.23% and 0.21%, 95% CI= 0.13%, 0.30%, respectively).
Additionally, both men and women who reported visiting a doctor in the past 12 months
reported a higher percentage of T2D related hospitalizations (0.63%, 95% CI= 0.59%,
0.77% and 0.45%, 95% CI= 0.40%, 0.49%, respectively) compared to men and women
who did not visit a doctor in past 12 months (0.23%, 95% CI= 0.17%, 0.30% and 0.37%,
95% CI= 0.27%, 0.47%, respectively). Both male and female current non-drinkers
reported higher T2D related hospitalizations (0.95%, 95% CI= 0.76%, 1.14% and 0.84%,
95% CI= 0.71%, 0.97%, respectively) compared to current drinkers (0.49%, 95% CI=
0.43%, 0.56% and 0.31%, 95% CI= 0.28%, 0.35%, respectively). Lastly, men who are
currently non-smokers reported a higher percentage of hospitalizations compared to
current smokers (0.62%, 95% CI= 0.53%, 0.70% and 0.39%, 95% CI= 0.32%, 0.47%,
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respectively). For women, the percentage of T2D related hospitalization reported for
current smokers and non-smokers was the approximately the same (0.44%, 95% CI=
0.35%, 0.52% and 0.43%, 95% CI= 0.39%, 0.48%, respectively).
With respect to continuous predictors, the mean age for individuals with a T2D related
hospitalization was 63.24 (SD=11.54) for men and 64.23 (SD=12.79) for women. This
was higher than the average age of non-hospitalized respondents: 43.70 (SD=16.39) and
45.52 (SD=17.25) for men and women, respectively. The hospitalized group had a lower
mean income category (7.2 [SD=1.96] for men, 6.14 [SD=1.98] for women) compared to
non-hospitalized respondents (8.18 [SD=2.17] for men, 7.66 [SD=2.36] for women).
Mean household size for non-hospitalized respondents was slightly higher (2.98
[SD=1.35] for men, 2.89 [SD=1.36] for women) compared to the hospitalized group
(2.27 [SD=0.90] for men, and 2.1 [SD=0.90] for women). Both men and women had a
higher mean BMI in the hospitalized group (28.86 [SD=4.41] and 28.77 [SD=5.91],
respectively) compared to the non-hospitalized respondents (26.36 [SD=2.49] and 25.07
[SD=5.18], respectively). For men, the mean MET was 1.65 (SD=1.67) in the
hospitalized group, whereas it was 2.31 (SD=2.44) in the non-hospitalized respondents.
For women, the mean MET was 1.16 (SD=1.21) in the hospitalized group while it was
1.95 (SD=2.04) in the non-hospitalized respondents. Lastly, men in the hospitalized
group reported slightly higher mean fruit and vegetable consumption (4.66 [SD=2.04])
compared to the non-hospitalized respondents (4.43 [SD=2.49]). In contrast, women in
the hospitalized group reported slightly lower mean fruit and vegetable consumption
(4.93 [SD=2.10]) compared to non-hospitalized respondents (5.11 [SD=2.57]).
Table 4.6: Cross tabulation of sociodemographic, health-related, and behavioural
predictors and type 2 diabetes related hospitalization among adults with unreported
type 2 diabetes

Variables
Mode of Interview
Telephone

Male ( n = 150,305)
T2D related hospitalization (n =
840)
95% Confidence
Percent
Interval
0.48

0.43

0.54

Female ( n = 183,415)
T2D related hospitalization (n
= 800)
95% Confidence
Percent
Interval
0.42

0.37

0.47
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In person
Age
Visible minority
White
Non-white
Marital status
Not married
Married
Education
Less than secondary
school
Secondary school or
more
Income
Household size
Rurality
Urban
Rural
BMI
Self-reported health
Poor
Good
Having a regular
doctor
No
Yes
Visit doctor in past
12 months
No
Yes
Alcohol Drinking
Currently non-drinker
Currently drinker
Smoking tobacco
Currently non-smoker
Currently smoker
Physical Activity
Fruit and vegetable
consumption

0.68
63.24 (11.54)

0.53
61.84

0.82
64.63

0.46
64.23 (12.79)

0.39
62.66

0.53
65.80

0.59
0.41

0.53
0.20

0.66
0.62

0.46
0.32

0.41
0.22

0.51
0.42

0.42
0.63

0.36
0.54

0.49
0.72

0.53
0.38

0.46
0.33

0.60
0.43

1.13

0.97

1.29

1.09

0.93

1.24

0.46

0.39

0.53

0.32

0.28

0.36

7.20 (1.96)
2.27 (0.90)

6.99
2.14

7.42
2.41

6.14 (1.98)
2.1 (0.90)

5.93
1.97

6.35
2.22

0.53
0.67
28.86 (4.41)

0.46
0.55
28.33

0.61
0.79
29.40

0.41
0.55
28.77 (5.91)

0.37
0.45
28.07

0.46
0.64
29.47

1.95
0.41

1.67
0.35

2.24
0.48

1.28
0.33

1.10
0.29

1.47
0.37

0.17
0.63

0.12
0.56

0.23
0.71

0.21
0.46

0.13
0.41

0.30
0.50

0.23
0.68

0.17
0.59

0.30
0.77

0.37
0.45

0.27
0.40

0.47
0.49

0.95
0.49

0.76
0.43

1.14
0.56

0.84
0.31

0.71
0.28

0.97
0.35

0.62
0.39
1.65 (1.67)

0.53
0.32
1.26

0.70
0.47
2.04

0.43
0.44
1.16 (1.21)

0.39
0.35
1.03

0.48
0.52
1.29

4.66 (2.04)

4.27

5.06

4.93 (2.10)

4.71

5.15

Note: Proportion and confidence interval are presented for categorical variables: mode of interview, visible
minority, marital status, education, rurality, self-reported health, having a regular doctor, visiting doctor in
past 12 months, alcohol drinking and smoking tobacco. Mean and standard deviation (SD) with
corresponding confidence intervals are presented for continuous variables: age, income, household size,
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BMI, physical activity, and fruits and vegetable consumption. Income and household size frequencies
distribution table were restricted outside RDC use due to low cell count in some categories.

Examination of the results from the multivariate logistic regression revealed year of
interview, age, age^2, BMI, self-reported health, and having a regular doctor were
statistically significant predictors of T2D related hospitalizations among men with
unreported T2D. Similarly, age, BMI and self-reported health were statistically
significant predictors of T2D related hospitalization among women with unreported T2D.
In contrast, for women, year of interview, age^2 and having a regular doctor were not
significant predictors of T2D related hospitalization, however, alcohol drinking, smoking
tobacco, and physical activity were significant predictors of T2D related hospitalization .
For men, year of interview remained significant after controlling for other covariates
(OR=1.07, 95% CI=1.03, 1.11). Examination of age revealed that in men, T2D related
hospitalization increased until 55 years of age, after which, T2D related hospitalizations
declined. Men also experienced higher odds of T2D related hospitalization with higher
BMI (OR=1.07, 95% CI=1.06, 1.09). Men who reported poor health had higher odds of
T2D related hospitalizations (OR=2.14, 95% CI=1.77, 2.58). Furthermore, having a
regular doctor increased the odds of T2D related hospitalization in men (OR=1.56, 95%
CI=1.07, 2.26).
For women, an increased odds of T2D hospitalization was observed until age 91, after
which, T2D related hospitalization declined. The quadratic term however was not
statistically significant in women. Among women, an increase in BMI was associated
with higher odds of T2D related hospitalization (OR=1.08, 95% CI=1.07, 1.10). Those
who reported poor health experienced higher odds of T2D related hospitalizations
(OR=1.64, 95% CI=1.31, 2.05). Additionally, women who were current drinkers had
lower odds of T2D related hospitalization (OR=0.67, 95% CI=0.53, 0.84). Those women
who were current smokers had higher odds of T2D related hospitalizations (OR=1.56,
95% CI=1.21, 2.00). Lastly, a higher level of physical activity was associated with lower
odds of hospitalization among women (OR=0.90, 95% CI=0.84, 0.97).
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Table 4.7: Association between sociodemographic, health-related and behavioural
predictors and type 2 diabetes related hospitalization among adults with unreported
type 2 diabetes
Male ( n = 150,305 )
Female ( n = 183,415 )
95%
95%
Odds
Odds
PVariables
Confidence
P-Value
Confidence
Ratio
Ratio
Value
Interval
Interval
Year of Interview 1.07
1.03
1.11
0.0005* 1.03
1.00
1.07
0.059
Mode of
1.14
0.88
1.49
0.3138
0.88
0.72
1.07
0.1945
Interview
Age
4.08
2.85
5.85
<.0001* 2.28
1.54
3.38
<.0001*
Age^2
0.91
0.87
0.94
<.0001* 0.96
0.92
1.00
0.0776
Visible minority
1.22
0.72
2.06
0.4640
1.25
0.88
1.79
0.2183
Marital status
0.93
0.71
1.21
0.5722
1.06
0.78
1.44
0.7183
Education
0.92
0.74
1.15
0.4797
0.88
0.71
1.09
0.2465
Income
0.96
0.91
1.01
0.1025
0.94
0.89
1.00
0.0548
Household size
0.91
0.78
1.06
0.2256
0.91
0.77
1.07
0.2457
Rurality
1.01
0.8
1.28
0.9466
1.15
0.93
1.42
0.2032
BMI
1.07
1.06
1.09
<.0001* 1.08
1.07
1.10
<.0001*
Self-reported
2.14
1.77
2.58
<.0001* 1.64
1.31
2.05
<.0001*
health
Having a regular
1.56
1.07
2.26
0.0196* 1.42
0.91
2.22
0.126
doctor
Visit doctor in
1.40
0.98
1.99
0.0642
0.88
0.65
1.19
0.4042
past 12 months
Alcohol drinking 0.83
0.65
1.05
0.1173
0.67
0.53
0.84
0.0006*
Smoking tobacco 1.02
0.80
1.3
0.875
1.56
1.21
2.00
0.0006*
Physical activity
0.95
0.83
1.08
0.4132
0.90
0.84
0.97
0.0049*
Fruit and
vegetable
1.03
0.98
1.08
0.2699
0.99
0.95
1.04
0.7183
consumption
Note: * denotes statistical significance at alpha=0.05
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Chapter 5

5

Discussion

This chapter will summarize the results of each objective of this study and attempt to
explain the findings. This chapter further lists the study strengths and limitations. Lastly,
this chapter will discuss the potential future directions and implications of this research
followed by a brief conclusion.

5.1 Key Findings
Between 2000 to 2009 among Canadian adults with unreported T2D, a higher percentage
of males compared to females experienced a T2D related hospitalization. In those with
unreported T2D, the percentage of T2D related hospitalization in men increased linearly
from 2000 to 2009. The percentage of T2D-related hospitalizations among women with
unreported T2D did not change from 2000 to 2009.
The results from the adjusted multivariate logistic regression revealed that year of
interview, age, BMI, self-reported poor health and having a regular doctor were
statistically significant predictors of T2D related hospitalizations in men who reported no
previous T2D diagnosis. Similarly, increasing age, higher BMI and self-reported poor
health also were significant predictors of T2D related hospitalization in women who
reported no previous T2D diagnosis. Furthermore, alcohol drinking, smoking tobacco,
and physical activity were also predictors of T2D related hospitalization in women who
reported no previous T2D diagnosis.

5.2 Percentage of type 2 diabetes related hospitalization
The percentage of men with unreported T2D who experienced a T2D related
hospitalization was higher than women between 2000 to 2009 (0.56% vs. 0.44%,
respectively). Past literature has shown that T2D rates are higher among men compared
to women, with men having 16% higher rates.[33] Men are also at risk for developing
T2D at a lower BMI compared to women, which may explain why T2D is more common
among men.[173] This may be because men are more likely to deposit fat in the
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abdominal region, whereas women are more likely to deposit fat subcutaneously and on
their lower extremities.[174] Adipose tissue in the abdominal region has been associated
with increased health risks, including T2D.[174]
The percentage of T2D related hospitalizations also increased linearly with time for men
but there was a not significant upward trend observed for women. There is research to
suggest that BMI has increased globally since 1980.[175] In Canada, 68% of men and
54% of women were estimated to be overweight or obese.[176] Additionally, between
1985 and 2011, the prevalence of obesity increased from 6.1% to 18.3%. Increases in
BMI might lead to an increase in newly diagnosed cases of T2D,[177] as obesity is a
significant risk factor for T2D development. Adults with a BMI of 40 or higher are 7.37
times more likely to be diagnosed with T2D.[50] The increase in BMI may explain the
increase in T2D hospitalization among unreported T2D individuals from 2000 to 2009.

5.3 Predictors of type 2 diabetes related hospitalization
5.3.1

Sociodemographic predictors

The findings from the current study show that CCHS respondents who reported no
previous T2D diagnoses and experienced T2D related hospitalization were, on average,
older than those who were not hospitalized. The adjusted multivariate logistic model
showed that among men, T2D related hospitalization increased until 55 years of age and
then decreased after that. Previous literature has shown that T2D related hospitalization
varies by age. A CIHI report indicated a rise in T2D preventable hospitalization event
until 40-59 years of age followed by a decreased observed from 60-74 years of age.[33]
In contrast, another study involving First Nations adults concluded that total
hospitalization among T2D patients decreases until 60 years of age and then increases
after that.[122] The reason for this pattern may be that those at risk of developing T2D do
so by 40-59 years of age. After that, the development of T2D might decline, as those who
are at risk or predisposed to developing T2D might have developed it already.[173,178]
The adjusted multivariate logistic model showed that among women, T2D related
hospitalization increased until 91 years of age and then decreased after that; however, the
quadratic term was not significant. According to a systematic review, more women are
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overweight or obese after the age of 45 years, whereas more males are overweight at a
younger age.[178] Women might develop T2D at an older age, which may explain why
T2D hospitalizations do not show a significant decline in women with increasing age.
Lastly, previous literature suggests that men are diagnosed with T2D at a lower BMI
than women.[173] Therefore, T2D hospitalization events might be occur at a younger
age in men and decline after that.
The results of this study showed that individuals in the white ethnic group reported a
higher percentage of T2D hospitalization. This was true for both men and women.
Furthermore, men who reported being married reported higher T2D related
hospitalization, while women who reported being married reported lower T2D related
hospitalization. In the adjusted multivariate logistic model, neither visible minority nor
marital status were statistically significant predictors of T2D related hospitalization.
Previous literature observed similar results; those who were married were less likely to
have a T2D related hospitalization event, but this was not significant after controlling for
confounders.[118] A Canadian study found that First Nations adults had almost four
times the odds of having a hospitalization or emergency department visit for a T2D
related events.[122] The rate of preventable hospitalizations among urban Métis adults
was found to be twice that of non-Indigenous adults.[126] However, the visible minority
variable used in this study was a binary variable (white/non-white) where the non-white
comprise of a mix of all ethnic groups. Not all ethnic groups share the same risk of T2D
and hospitalization risk. The effect of certain ethnic groups on hospitalization risk might
have diminished the effects of others. For example, immigrants from the Caribbean,
Europe and East Asia have been found to have lower odds of preventable hospitalization
and the effect may be transgenerational.[179]
Among men and women, a higher percentage of T2D related hospitalization were
reported among individuals with less than secondary schooling. Additionally, a lower
average mean income was reported for the T2D related hospitalization group. In the
adjusted multivariate logistic model, neither income nor education were statistically
significant for men or women; household size was controlled to standardize the
household income per individuals. These finding are in contrast to other studies. Findings
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from one study suggests that the effect of education is not significant after controlling for
income, which usually is a significant predictor of T2D related hospitalization.[118]
Another study, by Chen et al., found socioeconomic effects of higher education as well as
individual income were important factors which affect disparities in T2D related
hospitalization.[119] However, in the study by Chen et al., education was recorded at the
community level and they did not look at behavioural predictors.[119] Booth and Hux
found an inverse gradient between income level and T2D hospitalizations.[120]
However, Booth and Hux did not control for behavioural factors, and more importantly,
individual income was estimated from neighborhood income which may lead to
misclassification.[120] In the current study, there was not a significant effect of income
on T2D related hospitalization. This may suggest that universal care may be succeeding
in removing disparities associated with education and income. Additionally, income
might not be reliably reported in the CCHS dataset. For instance, income variable was
imputed due to 8.77% and 12.32% of the values missing for men and women.
Lastly, respondents who lived in rural areas were more likely to report hospitalization for
T2D, however in the adjusted multivariate logistic model, this variable was not
significant for males or females. In contrast, other studies have shown hospitalization
rates were 60% higher in rural areas compared to urban areas.[33] An Ontario study
found that more remote northern areas had higher rates of admission for hypoglycemia
and emergency department visits for T2D between 1994 through 1999; but these areas
experienced comparable or even greater declines in admission for hypoglycemia and
emergency department visits for T2D compared to areas in southern Ontario.[44] This
could indicate that efforts to mitigate the effects of accessibility in rural areas has been
successful. Furthermore, residence of rural areas are more likely to be obese or
overweight compared to urban dwellers.[180] After adjusting for BMI, the effects of
rurality might diminish.

5.3.2

Health-related predictors

On average, men and women hospitalized for T2D had higher BMI. Both men and
women who self-reported poor health also reported higher T2D related hospitalizations.
In the adjusted multivariate logistic model, both BMI and self-reported poor health were
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significant predictors of T2D related hospitalization for both men and women. Similar to
previous studies, adults with overweight and obesity tend to have increased incidence of
both general hospitalization and preventable hospitalization.[118,124] Furthermore, T2D
can be accompanied by several other health conditions and worse health status is a
predictor of hospitalization.[123] Previous studies have shown that having comorbidities
with T2D increases the odds of hospitalization; with one comorbidity having higher odds
of hospitalization compared to no comorbidity, and two or more comorbidities having
even higher odds of hospitalization.[119] Obesity in people with T2D is associated with
poor control of blood sugar, blood pressure and cholesterol levels; many of the health
complications of T2D become more severe when they are compounded by overweight or
obesity.[50–52] These contributing factors indicate why increased hospitalizations
occurred among respondents with higher BMI.

5.3.3

Behavioural predictors

The results showed that individuals who reported having a regular doctor and visiting a
doctor in the past 12 months also reported a higher percentage of T2D related
hospitalization among men and women. The adjusted multivariate logistic model
revealed that visiting a doctor in the past 12 months was not a significant predictor of
hospitalization in either men or women. However, having a regular doctor was
significantly associated with increased odds of hospitalization, but only for men. The
potential reasons for observing these results may be that a higher percentage of men who
have worse health seek to or are encouraged to have a regular doctor. Whereas women,
who are generally more health conscious,[181,182] might see their regular doctor before
their health worsens.
Previous literature reveals an equal percentage of hospitalization among those who
consulted a doctor in past 12 months and those who did not.[123] A different study
showed that, at an aggregated level, the average annual number of doctor visits per
person had a U-shaped association with hospitalizations for all conditions combined.
Specifically for patients with T2D, ischemic heart disease or renal disease, the lowest
number of hospitalizations were found when there was 20 to 30 doctor visits a year.[183]
A study from Alberta, Canada found that limited or increased use of primary care among
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T2D patients was associated with increased risk of a subsequent hospitalization.[128]
Those who visited primary care too much or too little were more likely to be
hospitalized.[128] Higher use of primary care services may indicate worse health. Also,
not using primary care services can lead to worsening of T2D related complications.[128]
These studies suggest that the relationship between the number of consultations with
doctor and hospitalizations might not be a linear relationship. In this study, the variable
indicating the number of visits to a doctor was a binary variable and a linear relationship
was not tested.
Among men, current non-drinkers and current non-smokers reported a higher percentage
of T2D hospitalizations. Among women, current drinkers and non-drinkers reported a
similar percentage of T2D related hospitalizations. In the adjusted multivariate logistic
model, smoking tobacco and alcohol drinking status was not a significant predictor of
T2D related hospitalization among men. In contrast, smoking tobacco and alcohol
drinking were significant predictors of T2D hospitalization among women. These results
align with previous Canadian literature which suggests that smoking is a risk factor for
hospitalization, whereas occasional/moderate alcohol drinking is a protective factor
against hospitalization.[123] Conflicting results come from some studies that aggregated
the results for men and women; for example, smoking status and alcohol consumption
were not related to T2D hospitalization.[118,184] However, this study examined these
predictors separately for men and women and it was found that alcohol drinking, smoking
tobacco and physical activity are significant predictors in women alone. Moderate alcohol
consumption has been shown to lower the risk of T2D. A systematic review found that
alcohol intake below 63 g/day played a protective role against T2D, with risk increasing
above that threshold.[66] However, reductions in risk appeared to be specific to women,
who exhibit a decreased risk of T2D.[66] A possible explanation for the sex differences
could be that men more frequently drink heavily compared to women.[185] Another
systematic review and meta-analysis showed moderate alcohol consumption might
improve insulin sensitivity among women.[186] Both former and current smoking has
been independently associated with a higher risk of incident T2D in men and
women.[187] Also, the smoking variable used in this study was a binary variable
indicating current smoking status. The reference group, current non-smokers, might have
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been contaminated with less healthy former smokers. This contamination might be higher
for men than women.
Lastly, results of this study show that men and women hospitalized for T2D had, on
average, a lower volume of physical activity measured in MET and less fruit and
vegetable consumption. In the adjusted multivariate logistic model, fruit and vegetable
consumption was not a significant predictor of T2D hospitalization for men or women.
Additionally, physical activity was not a significant predictor of T2D hospitalization for
men, however, it was a significant predictor for women. Previous literature has shown
that increased levels of physical activity can reduce preventable hospitalization in both
men and women.[118] There is strong evidence for an inverse association between
physical activity and risk of T2D, which may partly be mediated by reduced
adiposity.[71] Modifiable behaviours, which are correlated with one another, might also
have a greater influence on women. Other health behaviours such as increasing the
amount of green leafy vegetables in an individual’s diet has been shown to help reduce
the risk of T2D.[67,68] Habitual consumption of sugar sweetened beverages has been
shown to be associated with a greater incidence of T2D, independently of adiposity.[69]
Furthermore, meat consumption has shown to increase risk of T2D.[70] However, the
current study only measured fruit and vegetable consumption and did not control for
other food groups which might mitigate the effects of increased fruit and vegetable
consumption.

5.4 Strengths and Limitations
This study has both strengths and limitations. To our knowledge, this is the first Canadian
study to examine T2D related hospitalizations among patients with unreported T2D.
Also, this is the first Canadian study to look at temporal trends in T2D related
hospitalization among patients with unreported T2D. A major strength of this study is
that hospitalization data was used from hospitals across Canada, except Quebec. This
comprehensive data source represented ~75% of all hospital separations in Canada and
maintained standards for quality and consistency.[136] Additionally, the CCHS provides
a rich source of information on self-reported health status and determinants of health, but
lacks the details needed to study hospitalization events.[136] Linking the DAD with the
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CCHS helped generate a better understanding about what brings Canadians in contact
with acute care facilitates.[136] As a result of the large sample size, this study was able to
analyze a number of sociodemographic, health-related and behavioural predictors of T2D
related hospitalization.
One of the more significant limitations of this study was the self-reported T2D indicator
from the CCHS. In order for a person to self-report having diabetes, they must recognize
the term diabetes, have some knowledge of the disease, and associate the term with
themselves.[188] However, not all CCHS respondents who may have been diagnosed
with T2D will self-report that they have the disease. Respondents may not self-report
having T2D for the following reasons: they do not understand the term; they might have
never have been informed about the diagnosis; they have been informed of the diagnosis
but they may disagree with the diagnosis; they may believe, since they are managing their
condition, that the disease is cured; they may be aware and informed of T2D but are
hiding the diagnosis because of stigma.[188] A Canadian study in Ontario examined the
proportion of individuals with physician diagnosed T2D who reported having diabetes in
population health survey in 2001. They found that only 75% of people with physician
diagnosed T2D reported having the disease.[188] Additionally, respondents who did not
self-report their T2D status were more likely to be women, live in urban areas, and have a
shorter T2D disease duration.[188] Respondents who did not report their T2D status were
less likely to require hospital care for hyperglycaemia.[188]
Self-reported data might also have been subject to social desirability bias or recall bias.
For example, CCHS respondents might answer questions regarding health behaviours
more positively because they believe it to be more socially acceptable.[189] Additionally,
respondents might not remember accurately the answer to variables, such as fruit and
vegetable consumption.
This study employed a three-year follow-up period. We anticipated that if a CCHS
respondent reported no diagnosis of T2D at the time of their CCHS interview and was
hospitalized within three years for a T2D related condition, it is likely they had
undiagnosed T2D when the CCHS interview was conducted. However, individual may
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have seen a doctor or taken lab tests diagnosing them with diabetes during this follow-up
period. In which case, they would not be considered undiagnosed at the time of
hospitalization.
Non-response to the CCHS might have biased the results of this study, as well. The
CCHS response rate ranged from 69.8% to 78.9%.[137] The characteristics of those who
agreed to participate in the CCHS might be different than those who did not agree to
participate. Furthermore, 84.7% of those who completed the CCHS interview further
agreed to share their data for linkage.[151] The CCHS might also underestimate T2D
related hospitalizations due to selection bias. For instance, excluded from the CCHS are:
persons living on reserves and other Aboriginal settlements, full-time members of the
Canadian Forces, and institutionalized population.[137] The excluded population might
possess different characteristics compared to the included population. For example,
people living on reserves might have a higher T2D related hospitalizations.
Another limitation of this study is that this thesis did not utilized laboratory data or
physician billing to confirm T2D diagnosis and investigate clinical predictors of T2D
related hospitalizations. Furthermore, a qualitative study found that variables such as
extreme social vulnerability (such as homeless, poverty and no social support), health
system interaction issues (such as poor communication with providers), limited healthrelated knowledge, behavioural health issues (such as substance abuse and mental
illness), denial of illness and practical problems (such as being too busy) were some of
the reasons listed for T2D related hospitalizations.[190] This study did not control for
these factors, which might lead to residual confounding. Other important factors such as
comorbidity was also not controlled for; which has also been linked to elevating diabetes
hospitalizations.[191]
The DAD might also underestimate T2D related diagnosis. A Spanish study examined a
cohort of 1036 patients admitted to a hospital over a seven-day period. They found 178
patients had T2D; 15% of admitted patients had previously diagnosed and 1.9% had been
newly diagnosed. Out of the 178 T2D cases, 144 were recorded in the discharge record,
that is 19% of T2D cases were not reported in administrative datasets.[192] Other studies

72

have also shown under-reporting of T2D cases in a hospital setting.[31,193,194]
Therefore, the true incidence of T2D hospitalization among self-reported undiagnosed
diabetes might be underestimated.
The variable utilized to represent the construct of income had limitations as well. First,
the income variable was not standardized to geographic differences in cost of living.
Secondly, the income categories representing low-high income on a scale of 0-10
remained constant over the CCHS cohorts used in this study. This is problematic as lowhigh income cutoffs change over place and time. Although the CCHS over the years has
developed income variables that are standardized to account for variability over place and
time, these variables were not available in the early years of the survey and were not
available for the Canadian territories.
Lastly, poor measurement of constructs such as alcohol drinking, fruits and vegetable
consumption, BMI can create bias which can distort study results. For example, CCHS
participants were asked to recall if they drank in the past year, however, this did not
include how much alcohol was consumed. Excessive drinking might pose a larger
problem than drinking frequency.[195] Another poor measurement of construct might
have been fruits and vegetable consumption. CCHS respondents were asked to recall the
frequency of fruits and vegetable consumption. However, this may be subject to recall
bias. Furthermore, measurement of other unhealthy food choices was not assessed.
Lastly, studies have shown that measurements such as waist circumference and waist to
hit ratio are slightly better at predicting diabetes and diabetes complications in both sexes
compared to BMI.[196,197]

5.5 Implications and further direction
In direct response to the potential limitations of the present study, it is of interest to
utilize more reliable methods of ascertaining undiagnosed T2D and T2D related
hospitalizations. Ensuring health administrative dataset are capturing diagnosis accurately
and using clinical data, such as laboratory tests, to ascertain outcome.
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The results of this thesis align with previous literature suggesting T2D prevalence tends
to be higher in men,[33] and men also develop T2D at a lower BMI compared to
women.[173] Similarly, undiagnosed T2D is higher in men compared to women.[79,80]
Practical implications of this finding can include health care providers being aware of the
higher risk of T2D incidence among men. Higher incidence of T2D in men can lead to
higher rates of T2D cases going undiagnosed. Therefore, theoretically, screening in men
should occur at a lower BMI compared to women. Previous literature has examined why
men experience higher rates of T2D compared to women and suggests that adipose tissue
is associated with increased risk of T2D and men are more likely to deposit fat in the
abdominal region compared to women.[174] However, there is no consensus on why men
experience higher rates of T2D compared to women. Future research should focus on the
causal pathway of T2D and how this differs between genders, including non-binary
groups.
Percentage of T2D related hospitalization among unreported T2D patients increased from
the period 2000-2009. Research suggests an increase in overweight and obesity in
Canada, more so in men than in women.[176] Increases in BMI might lead to an increase
in newly diagnosed cases of T2D.[177] This should raise the alarm for policy makers and
health care providers as with increasing economic costs, diagnosing T2D at an early stage
is key to affording the opportunity to treat T2D, and T2D control is key to reducing the
risk of complications. Future research should assess reasons for the rise in T2D related
hospitalization among undiagnosed T2D Canadians, given that crude T2D related are
decreasing.
In the US, there is evidence to suggest that undiagnosed T2D crude prevalence increased
during the past two decades but has decreased over time as a proportion of total T2D
cases.[90] Although there is literature in Canada that aims to estimate the prevalence of
undiagnosed T2D, there is a lack of literature on temporal trends in crude undiagnosed
T2D prevalence in the Canadian context. Due to the lack of Canadian literature on
national trends in crude undiagnosed T2D prevalence, the rise in T2D related
hospitalization among undiagnosed T2D Canadian cannot directly be compared. Future
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research should concentrate on examining national trends in crude undiagnosed T2D
prevalence.
The results from the adjusted multivariate logistic regression revealed that age, BMI, selfreported health and having a regular doctor were statistically significant predictors of
T2D related hospitalizations in Canadian adults. Whereas, visible minority, income and
rurality were not significant predictors of T2D related hospitalization. These findings are
in contrast to other studies on ethnicity,[122,126,179] income,[118–120] and rurality.[33]
Modifiable health behaviours such as drinking alcohol, smoking tobacco and physical
activity were associated with T2D related hospitalization among women. The practical
implications of these finding are that modifiable health behaviours can aid in creating a
healthier society and these modifiable health behaviours might be more important in
women’s health. This thesis could not explain why males and females differed in their
predictors for T2D related hospitalization. Future research should aim to explore the sex
differences observed in T2D related hospitalization for modifiable health behaviours.
While much research focuses on predictors of T2D related hospitalization among people
with T2D in Canada, more research needs to focus on understanding the determinants of
T2D related hospitalization among people with undiagnosed T2D and how they are
associated with experiencing undiagnosed T2D and subsequent preventable
hospitalization. This thesis was not able to examine clinical predictors, such FPG levels,
which have been previously associated with increased T2D hospitalization risk.[114]
With plans for linkage projects involving the CCHS and the CIHI datasets in the future,
research should examine clinical predictors, as well as controlling for a plethora of other
confounders of T2D related hospitalization.

5.6 Conclusion
Between 2000 and 2009, a higher percentage of males compared to females with
unreported T2D experienced a T2D related hospitalization event. Identifying undiagnosed
diabetes could be an effective strategy to minimize the long‐term impacts of the disease.
Screening intervention could permit timely initiation of therapy designed to prevent or
delay the occurrence of complications. Additionally, this thesis examined the temporal
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trends in T2D related hospitalization among individuals with unreported T2D. The
percentage of T2D related hospitalizations among men with unreported T2D increased
linearly from 2000 to 2009. With the rise in T2D related hospitalizations among
individuals with unreported T2D, potentially due to increased prevalence of obesity and
newly, policymakers should address this issue.
Lastly, this thesis explored potential sociodemographic, health-related and behavioural
predictors of T2D related hospitalization among individuals with undiagnosed T2D. The
adjusted multivariate logistic regression revealed that age, BMI, self-reported health were
significant predictors of T2D related hospitalizations in men and women. However,
alcohol drinking, smoking tobacco, and physical activity were significant predictors of
T2D related hospitalization in women only. Modifiable health behaviours might have a
greater influence on women. While the current analysis was not able to ascertain
causality, future research should focus on understanding these relationships. Future
research should also focus on linking other administrative datasets, such as physician
billing or laboratory results, to ascertain T2D diagnosis status. Furthermore, identifying
undiagnosed T2D could be an effective strategy to minimize the long‐term impacts of the
disease.
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Appendices
Appendix A: Description of ICD-10 codes and their corresponding ICD-9 codes
ICD10-CA
E1100

Description
TYPE 2 DIABETES
MELLITUS WITH
HYPEROSMOLARITY
WITHOUT NONKETOTIC
HYPERGLYCEMICHYPEROSMOLAR COMA
(NKHHC)

E1101

TYPE 2 DIABETES
MELLITUS WITH
HYPEROSMOLARITY WITH
COMA

E1121

TYPE 2 DIABETES
MELLITUS WITH DIABETIC
NEPHROPATHY

E1129

TYPE 2 DIABETES
MELLITUS WITH OTHER
DIABETIC KIDNEY
COMPLICATION
E11311 TYPE 2 DIABETES
MELLITUS WITH
UNSPECIFIED DIABETIC
RETINOPATHY WITH
MACULAR EDEMA

E11319 TYPE 2 DIABETES
MELLITUS WITH

ICD- Description
9
25020 DIABETES MELLITUS WITH
HYPEROSMOLARITY TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED

25022 DIABETES MELLITUS WITH
HYPEROSMOLARITY TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
25020 DIABETES MELLITUS WITH
HYPEROSMOLARITY TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
25032 DIABETES MELLITUS WITH
OTHER COMA TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
25042 DIABETES MELLITUS WITH
RENAL MANIFESTATIONS TYPE II
OR UNSPECIFIED TYPE
UNCONTROLLED
25040 DIABETES MELLITUS WITH
RENAL MANIFESTATIONS TYPE II
OR UNSPECIFIED TYPE NOT
STATED AS UNCONTROLLED
25050 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
NOT STATED AS UNCONTROLLED
25052 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED
36207 DIABETIC MACULAR EDEMA
25050 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
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UNSPECIFIED DIABETIC
RETINOPATHY WITHOUT
MACULAR EDEMA

E11329 TYPE 2 DIABETES
MELLITUS WITH MILD
NONPROLIFERATIVE
DIABETIC RETINOPATHY
WITHOUT MACULAR
EDEMA

E11339 TYPE 2 DIABETES
MELLITUS WITH
MODERATE
NONPROLIFERATIVE
DIABETIC RETINOPATHY
WITHOUT MACULAR
EDEMA
E11349 TYPE 2 DIABETES
MELLITUS WITH SEVERE
NONPROLIFERATIVE
DIABETIC RETINOPATHY
WITHOUT MACULAR
EDEMA
E11359 TYPE 2 DIABETES
MELLITUS WITH
PROLIFERATIVE DIABETIC
RETINOPATHY WITHOUT
MACULAR EDEMA
E1136 TYPE 2 DIABETES
MELLITUS WITH DIABETIC
CATARACT

TYPE II OR UNSPECIFIED TYPE
NOT STATED AS UNCONTROLLED
25052 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED
36201 BACKGROUND DIABETIC
RETINOPATHY
36203 NONPROLIFERATIVE DIABETIC
RETINOPATHY NOS

36204 MILD NONPROLIFERATIVE
DIABETIC RETINOPATHY
36205 MODERATE NONPROLIFERATIVE
DIABETIC RETINOPATHY

36206 SEVERE NONPROLIFERATIVE
DIABETIC RETINOPATHY

36202 PROLIFERATIVE DIABETIC
RETINOPATHY

25050 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
NOT STATED AS UNCONTROLLED
25052 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED
36641 DIABETIC CATARACT
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E1139

TYPE 2 DIABETES
MELLITUS WITH OTHER
DIABETIC OPHTHALMIC
COMPLICATION

E1140

TYPE 2 DIABETES
MELLITUS WITH DIABETIC
NEUROPATHY,
UNSPECIFIED

E1142

TYPE 2 DIABETES
MELLITUS WITH DIABETIC
POLYNEUROPATHY
TYPE 2 DIABETES
MELLITUS WITH DIABETIC
PERIPHERAL
ANGIOPATHY WITHOUT
GANGRENE

E1151

E11618 TYPE 2 DIABETES
MELLITUS WITH OTHER
DIABETIC ARTHROPATHY

E11620 TYPE 2 DIABETES
MELLITUS WITH DIABETIC
DERMATITIS

E11621 TYPE 2 DIABETES
MELLITUS WITH FOOT
ULCER

25050 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
NOT STATED AS UNCONTROLLED
25052 DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED
25060 DIABETES MELLITUS WITH
NEUROLOGICAL
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
25062 DIABETES MELLITUS WITH
NEUROLOGICAL
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
3572 POLYNEUROPATHY IN DIABETES

25070 DIABETES MELLITUS WITH
PERIPHERAL CIRCULATORY
DISORDERS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
25072 DIABETES MELLITUS WITH
PERIPHERAL CIRCULATORY
DISORDERS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
25080 DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
25080 DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
25080 DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
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E11622 TYPE 2 DIABETES
MELLITUS WITH OTHER
SKIN ULCER

25080

E11628 TYPE 2 DIABETES
MELLITUS WITH OTHER
SKIN COMPLICATIONS

25080

E11630 TYPE 2 DIABETES
MELLITUS WITH
PERIODONTAL DISEASE

25080

E11638 TYPE 2 DIABETES
MELLITUS WITH OTHER
ORAL COMPLICATIONS

25080

E11641 TYPE 2 DIABETES
MELLITUS WITH
HYPOGLYCEMIA WITH
COMA
E11649 TYPE 2 DIABETES
MELLITUS WITH
HYPOGLYCEMIA
WITHOUT COMA

25030

E1165

25002

TYPE 2 DIABETES
MELLITUS WITH
HYPERGLYCEMIA

25080

25012

25022

25032

UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER COMA TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITHOUT
COMPLICATION TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
KETOACIDOSIS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
HYPEROSMOLARITY TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
OTHER COMA TYPE II OR
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25042

25052

25062

25072

25080

25082

25092

E1169

TYPE 2 DIABETES
MELLITUS WITH OTHER
SPECIFIED
COMPLICATION

25010

25012

25080

UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
RENAL MANIFESTATIONS TYPE II
OR UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
OPHTHALMIC MANIFESTATIONS
TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
NEUROLOGICAL
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
PERIPHERAL CIRCULATORY
DISORDERS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
UNSPECIFIED COMPLICATION
TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
KETOACIDOSIS TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
KETOACIDOSIS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
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25082

E118

TYPE 2 DIABETES
MELLITUS WITH
UNSPECIFIED
COMPLICATIONS

25090

25092

E119

TYPE 2 DIABETES
MELLITUS WITHOUT
COMPLICATIONS

25000

UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
DIABETES MELLITUS WITH
OTHER SPECIFIED
MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITH
UNSPECIFIED COMPLICATION
TYPE II OR UNSPECIFIED TYPE
NOT STATED AS UNCONTROLLED
DIABETES MELLITUS WITH
UNSPECIFIED COMPLICATION
TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED
DIABETES MELLITUS WITHOUT
COMPLICATION TYPE II OR
UNSPECIFIED TYPE NOT STATED
AS UNCONTROLLED
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Appendix B: Association between sociodemographic, health-related and
behavioural predictors and type 2 diabetes related hospitalization among adults
with unreported type 2 diabetes: Results from Unimputed dataset
Variables
Year of
Interview
Type of
Interview
Age
Age^2
Visible
Minority
Marital
status
Education
Income
Household
size
Rurality
BMI
Selfreported
health
Having a
regular
doctor
Visit doctor
in past 12
months
Alcohol
drinking
Smoking
Physical
activity
Fruit and
vegetable
consumption

Odds
Ratio

95% Confidence
Interval

P-Value

Odds
Ratio

95% Confidence
Interval

P-Value

1.07

1.03

1.12

0.0007*

1.04

1.00

1.08

0.0348*

1.15

0.85

1.56

0.3543

0.93

0.74

1.16

0.5145

3.40
0.93

2.30
0.89

5.02
0.97

<.0001*
0.0011*

1.96
0.98

1.29
0.94

2.97
1.02

0.0018*
0.316

1.24

0.65

2.36

0.5157

1.63

1.11

2.41

0.0133*

0.89

0.66

1.21

0.4713

1.33

0.95

1.86

0.1023

0.94
0.96

0.73
0.91

1.20
1.01

0.5988
0.1047

0.92
0.93

0.72
0.87

1.19
1.00

0.5345
0.0481*

0.90

0.76

1.07

0.2199

0.76

0.64

0.90

0.0021*

1.08
1.07

0.82
1.05

1.42
1.09

0.6031
<.0001*

1.13
1.09

0.87
1.07

1.46
1.10

0.3805
<.0001*

1.95

1.58

2.41

<.0001*

1.92

1.47

2.52

<.0001*

1.68

1.12

2.52

0.0124*

1.53

0.89

2.64

0.1245

1.52

1.02

2.27

0.0385*

0.81

0.55

1.20

0.2917

1.00

0.77

1.31

0.9799

0.75

0.59

0.95

0.0164*

1.06

0.81

1.38

0.6662

1.48

1.08

2.03

0.0143*

0.95

0.81

1.11

0.5095

0.88

0.80

0.96

0.0052*

1.03

0.97

1.10

0.2937

1.01

0.96

1.05

0.8298
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